<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ESC Heart Fail</journal-id><journal-id journal-id-type="iso-abbrev">ESC Heart Fail</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2055-5822</journal-id><journal-id journal-id-type="publisher-id">EHF2</journal-id><journal-title-group><journal-title>Esc Heart Failure</journal-title></journal-title-group><issn pub-type="epub">2055-5822</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27347426</article-id><article-id pub-id-type="pmc">4864752</article-id><article-id pub-id-type="doi">10.1002/ehf2.12027</article-id><article-id pub-id-type="publisher-id">EHF212027</article-id><article-id pub-id-type="other">ESCHF-2014-11-0020.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research Articles</subject></subj-group></article-categories><title-group><article-title>Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design</article-title><alt-title alt-title-type="left-running-head">R.T. Campbell <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running-head">PCHF: rationale and design</alt-title></title-group><contrib-group><contrib id="ehf212027-cr-0001" contrib-type="author" corresp="yes"><name><surname>Campbell</surname><given-names>Ross T.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ehf212027-cr-0002" contrib-type="author"><name><surname>Jackson</surname><given-names>Colette E.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ehf212027-cr-0003" contrib-type="author"><name><surname>Wright</surname><given-names>Ann</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ehf212027-cr-0004" contrib-type="author"><name><surname>Gardner</surname><given-names>Roy S.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ehf212027-cr-0005" contrib-type="author"><name><surname>Ford</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="ehf212027-cr-0006" contrib-type="author"><name><surname>Davidson</surname><given-names>Patricia M.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="ehf212027-cr-0007" contrib-type="author"><name><surname>Denvir</surname><given-names>Martin A.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="ehf212027-cr-0008" contrib-type="author"><name><surname>Hogg</surname><given-names>Karen J.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="ehf212027-cr-0009" contrib-type="author"><name><surname>Johnson</surname><given-names>Miriam J.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="ehf212027-cr-0010" contrib-type="author"><name><surname>Petrie</surname><given-names>Mark C.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="ehf212027-cr-0011" contrib-type="author"><name><surname>McMurray</surname><given-names>John J.V.</given-names></name><xref ref-type="aff" rid="ehf212027-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="ehf212027-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">BHF Glasgow Cardiovascular Research Centre</named-content><institution>University of Glasgow</institution><named-content content-type="city">Glasgow</named-content><named-content content-type="country-part">Scotland</named-content><country country="GB">UK</country></aff><aff id="ehf212027-aff-0002"><label><sup>2</sup></label><institution>Golden Jubilee National Hospital</institution><named-content content-type="street">Clydebank</named-content><country country="GB">UK</country></aff><aff id="ehf212027-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Robertson Centre for Biostatistics</named-content><institution>University of Glasgow</institution><country country="GB">UK</country></aff><aff id="ehf212027-aff-0004"><label><sup>4</sup></label><institution>Johns Hopkins University</institution><named-content content-type="city">Baltimore</named-content><named-content content-type="country-part">MD</named-content><country country="US">USA</country></aff><aff id="ehf212027-aff-0005"><label><sup>5</sup></label><institution>Edinburgh University</institution><named-content content-type="city">Edinburgh</named-content><country country="GB">UK</country></aff><aff id="ehf212027-aff-0006"><label><sup>6</sup></label><institution>Glasgow Royal Infirmary</institution><country country="GB">UK</country></aff><aff id="ehf212027-aff-0007"><label><sup>7</sup></label><named-content content-type="organisation-division">Hull York Medical School</named-content><institution>University of Hull</institution><named-content content-type="city">Hull</named-content><country country="GB">UK</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Ross T. Campbell, BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, G12 8TA, UK. Tel: +44 141 330 3479; Fax: +44 141 330 6955.<break/>
Email: <email>ross.campbell@glasgow.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2015</year></pub-date><volume>2</volume><issue>1</issue><issue-id pub-id-type="doi">10.1002/ehf2.v2.1</issue-id><fpage>25</fpage><lpage>36</lpage><history><date date-type="received"><day>17</day><month>11</month><year>2014</year></date><date date-type="rev-recd"><day>18</day><month>2</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2015</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2015 John Wiley & Sons, Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2015 The Authors. ESC Heart Failure published by John Wiley &#x00026; Sons Ltd on behalf of the European Society of Cardiology.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EHF2-2-25.pdf"/><abstract><title>Abstract</title><sec id="ehf212027-sec-0001"><title>Aims</title><p>The primary aim of this study is to provide data to inform the design of a randomized controlled clinical trial (RCT) of a palliative care (PC) intervention in heart failure (HF). We will identify an appropriate study population with a high prevalence of PC needs defined using quantifiable measures. We will also identify which components a specific and targeted PC intervention in HF should include and attempt to define the most relevant trial outcomes.</p></sec><sec id="ehf212027-sec-0002"><title>Methods</title><p>An unselected, prospective, near&#x02010;consecutive, cohort of patients admitted to hospital with acute decompensated HF will be enrolled over a 2&#x02010;year period. All potential participants will be screened using B&#x02010;type natriuretic peptide and echocardiography, and all those enrolled will be extensively characterized in terms of their HF status, comorbidity, and PC needs. Quantitative assessment of PC needs will include evaluation of general and disease&#x02010;specific quality of life, mood, symptom burden, caregiver burden, and end of life care. Inpatient assessments will be performed and after discharge outpatient assessments will be carried out every 4&#x02009;months for up to 2.5&#x02009;years. Participants will be followed up for a minimum of 1&#x02009;year for hospital admissions, and place and cause of death. Methods for identifying patients with HF with PC needs will be evaluated, and estimates of healthcare utilisation performed.</p></sec><sec id="ehf212027-sec-0003"><title>Conclusion</title><p>By assessing the prevalence of these needs, describing how these needs change over time, and evaluating how best PC needs can be identified, we will provide the foundation for designing an RCT of a PC intervention in HF.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ehf212027-kwd-0001">Heart failure</kwd><kwd id="ehf212027-kwd-0002">Palliative care</kwd></kwd-group><funding-group><award-group><funding-source>British Heart Foundation</funding-source><award-id>PG/13/17/30050</award-id></award-group></funding-group><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>ehf212027</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2015</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.1 mode:remove_FC converted:23.06.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="ehf212027-cit-0000">
<string-name>
<surname>Campbell</surname>, <given-names>R. T.</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>, <given-names>C. E.</given-names>
</string-name>, <string-name>
<surname>Wright</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gardner</surname>, <given-names>R. S.</given-names>
</string-name>, <string-name>
<surname>Ford</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>, <given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Denvir</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Hogg</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Petrie</surname>, <given-names>M. C.</given-names>
</string-name>, and <string-name>
<surname>McMurray</surname>, <given-names>J. J.</given-names>
</string-name> (<year>2015</year>), <article-title>Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design</article-title>. <source>ESC Heart Failure</source>, <volume>2</volume>: <fpage>25</fpage>&#x02013;<lpage>36</lpage>. doi: <ext-link ext-link-type="doi" xlink:href="10.1002/ehf2.12027">10.1002/ehf2.12027</ext-link>.</mixed-citation>
</p></notes></front><body><sec id="ehf212027-sec-0004"><title>Background</title><p>Heart failure (HF) is common, affecting 1&#x02013;2% of the general population with the prevalence rising to over 10% in those aged over 80&#x02009;years.<xref rid="ehf212027-bib-0001" ref-type="ref">1</xref>, <xref rid="ehf212027-bib-0002" ref-type="ref">2</xref> HF leads to a reduced life expectancy, with 5 and 10&#x02009;year survival rates of 50 and 10% ,respectively, reported in epidemiological studies.<xref rid="ehf212027-bib-0003" ref-type="ref">3</xref>, <xref rid="ehf212027-bib-0004" ref-type="ref">4</xref> These poor survival rates have led to comparisons with cancer.<xref rid="ehf212027-bib-0005" ref-type="ref">5</xref> Therefore, it would seem intuitive that some patients with HF may benefit from specialist palliative care (PC), given the poor survival and high symptom and care&#x02010;giver burden associated with this condition. The World Health Organization (WHO) defines PC as an approach that improves the quality of life (QOL) of patients and their families facing the problem associated with life&#x02010;threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial, and spiritual.<xref rid="ehf212027-bib-0006" ref-type="ref">6</xref> Contemporary HF guidelines have begun to recommend that PC be considered in patients with advanced HF refractory to optimal, or maximally tolerated, contemporary, disease&#x02010;modifying drug and device therapies, and where the resultant symptom burden is high and prognosis poor.<xref rid="ehf212027-bib-0007" ref-type="ref">7</xref>, <xref rid="ehf212027-bib-0008" ref-type="ref">8</xref>, <xref rid="ehf212027-bib-0009" ref-type="ref">9</xref>, <xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> These recommendations are, however, based on relatively limited evidence and no substantial and systematic study of the actual and specific PC needs of patients with HF (and their caregivers) has been undertaken. It is possible that despite a reduced life&#x02010;expectancy, many patients with HF do not require specific or specialist PC&#x02014;for example those who remain only slightly functionally limited by symptoms before a sudden death (and sudden death is relatively more common in patients with mild symptoms).<xref rid="ehf212027-bib-0011" ref-type="ref">11</xref> However, a proportion of patients with HF almost certainly do require PC but, as yet, we do not know how large or small this group is.</p><p>Although many small studies and recent systematic reviews of these have suggested likely unmet PC needs of patients with HF,<xref rid="ehf212027-bib-0012" ref-type="ref">12</xref>, <xref rid="ehf212027-bib-0013" ref-type="ref">13</xref> the true prevalence of these needs is difficult to quantify for a number of reasons. As well as being small, most of the studies included highly selected patients or described cohorts with HF and a variety of other conditions. Secondly, the patients with HF were often not clearly described, and because natriuretic peptides and echocardiography were rarely used, the diagnosis of HF in some is uncertain. Furthermore, any differences in PC needs between HF with preserved ejection fraction (HF&#x02010;PEF), which accounts for half of all cases in some cohorts,<xref rid="ehf212027-bib-0014" ref-type="ref">14</xref>, <xref rid="ehf212027-bib-0015" ref-type="ref">15</xref> and HF with reduced ejection fraction (HF&#x02010;REF) have not been described. Most studies to date have been cross&#x02010;sectional and have not, therefore, described how PC needs change over time. Finally, many of the existing studies have used qualitative techniques, meaning their findings cannot be quantified or translated to other populations. A systematic study describing the prevalence of PC needs (and the specifics of these), using quantifiable measures, in an unselected, real&#x02010;life cohort of patients with HF, is required. As HF is a condition known to fluctuate, a single assessment, cross&#x02010;sectional study design is unlikely to identify those with a sustained need for a palliative&#x02010;intervention, and serial measurement is essential.</p><p>Whether PC is a worthwhile intervention in HF is unknown because no substantial randomized controlled clinical trial (RCT) has been performed. An RCT of PC in terminal conditions is, however, possible. One RCT of an early PC intervention in patients with lung cancer has been performed, with a suggestion that early PC can improve QOL and reduce healthcare utilisation.<xref rid="ehf212027-bib-0016" ref-type="ref">16</xref> However, a more recent RCT of early PC in patients with advanced cancer did not show a significant improvement in the primary outcome of QOL in the early PC arm.<xref rid="ehf212027-bib-0017" ref-type="ref">17</xref> While some of these results are encouraging, the symptoms and needs of patients with HF who are approaching the end of life may be quite different from patients with cancer, and the design of a potential RCT of PC in HF must consider this. Measures for assessing PC needs in patients with HF require further evaluation before being applied in a large RCT in HF. Another notable trial was conducted in patients deemed terminally ill as a result of a number of different illness and were housebound (33% of study participants had HF, 47% had cancer, and 21% had chronic obstructive airways disease). This trial compared usual care to usual care plus PC at home, delivered by a multi&#x02010;disciplinary team.<xref rid="ehf212027-bib-0018" ref-type="ref">18</xref> Participants in the PC arm experienced significantly greater patient satisfaction, reduced use of medical services and healthcare costs, and were more likely to die at home than in a hospital. Although this study was well designed and informative, the cohort was mixed and the characteristics of the patients with HF were not clearly described. In particular, there was no differentiation between HF&#x02010;PEF and HF&#x02010;REF and no description of HF treatment. More recently, a single centre, RCT of PC in HF, randomized 72 outpatients with HF&#x02010;REF NYHA class III/IV to receive either early PC and HF care together or standard care.<xref rid="ehf212027-bib-0019" ref-type="ref">19</xref> Assessments of QOL and symptoms were made at 1, 3 and 6&#x02009;months and patients were followed up for HF hospitalisations for 6&#x02009;months. The PC arm experienced greater improvements in QOL and had fewer HF hospitalisations. These results are encouraging, however, the numbers of patients were small and patients with HF&#x02010;PEF were not represented. A large RCT of PC in HF is needed to build upon these preliminary findings. Before such a trial can be designed, suitable outcome measures and tools for identifying patients with PC needs must be assessed in a real&#x02010;life population of patients with HF.</p><sec id="ehf212027-sec-0006"><title>Study aims</title><p>Ultimately, the goal of this study is to provide the foundation for an RCT of a PC intervention in HF. This will include characterisation of an appropriate study population, identifying the components of a specific and targeted PC intervention, and defining potential trial outcomes. To achieve this goal, we will address the following specific points: 
<list list-type="order" id="ehf212027-list-0002"><list-item id="ehf212027-li-0010"><p>Describe and quantify the supportive and PC needs of a cohort of patients hospitalized with HF (and the needs of their caregivers). Specifically, describe and quantify general and disease&#x02010;specific QOL, symptom burden, caregiver burden, mood, performance status, and preferences for end of life (EOL) care of these patients.</p></list-item><list-item id="ehf212027-li-0011"><p>Evaluate whether estimated poor prognosis or recognized assessment tools used in other populations (e.g. patients with cancer) can identify patients with hospitalized HF who have PC needs.</p></list-item><list-item id="ehf212027-li-0012"><p>Describe the healthcare utilisation of patients hospitalized with HF, and describe any differences between those with and without PC needs.</p></list-item><list-item id="ehf212027-li-0013"><p>Using the findings from items 1&#x02013;3, design an RCT of a PC intervention for HF. In particular, we will identify an appropriate population with a high PC need (and describe how to identify this need), define the components of an HF&#x02010;specific and targeted PC intervention, and suggest potential outcome measures for such a trial.</p></list-item></list>
</p></sec></sec><sec id="ehf212027-sec-0007"><title>Rationale and study design</title><sec id="ehf212027-sec-0008"><title>Describing the supportive and palliative care needs of patients with heart failure</title><p>Although there have been descriptions of unmet supportive and PC needs of patients with HF, these needs have not been described using reproducible and quantifiable measures in a &#x02018;real world&#x02019; HF population. Any such description should take into account the WHO definition of PC,<xref rid="ehf212027-bib-0006" ref-type="ref">6</xref> and therefore not only make an assessment of EOL care needs, but also the QOL of patients and their caregivers, mood and symptom burden.</p></sec><sec id="ehf212027-sec-0009"><title>Quality of life</title><p>It is unclear which QOL tool is best in patients with HF, although a combination of a HF specific and a generic questionnaire may be optimal.<xref rid="ehf212027-bib-0020" ref-type="ref">20</xref> One of the most commonly used HF specific questionnaires is the Kansas City Cardiomyopathy Questionnaire (KCCQ).<xref rid="ehf212027-bib-0021" ref-type="ref">21</xref> This has been widely used in a number of HF studies and has been well validated.<xref rid="ehf212027-bib-0022" ref-type="ref">22</xref>, <xref rid="ehf212027-bib-0023" ref-type="ref">23</xref>, <xref rid="ehf212027-bib-0024" ref-type="ref">24</xref>, <xref rid="ehf212027-bib-0025" ref-type="ref">25</xref> A variety of generic QOL assessment tools are available and one of the most widely used is the SF&#x02010;36,<xref rid="ehf212027-bib-0026" ref-type="ref">26</xref> which has been validated in a variety of populations including HF.<xref rid="ehf212027-bib-0027" ref-type="ref">27</xref>, <xref rid="ehf212027-bib-0028" ref-type="ref">28</xref> This has been shortened to a 12 question format, while retaining validity,<xref rid="ehf212027-bib-0029" ref-type="ref">29</xref> in the form of the Short Form 12 (SF&#x02010;12).<xref rid="ehf212027-bib-0029" ref-type="ref">29</xref>, <xref rid="ehf212027-bib-0030" ref-type="ref">30</xref>
</p><p>Heart failure not only affects patients' QOL, but also that of their caregivers.<xref rid="ehf212027-bib-0031" ref-type="ref">31</xref> Caregiver QOL can be readily assessed using a generic tool, such as SF&#x02010;12, but assessing &#x02018;caregiver burden&#x02019; within a family as a result of HF can also be assessed using the Zarit Burden Interview.<xref rid="ehf212027-bib-0032" ref-type="ref">32</xref> This is the most widely used and validated caregiver assessment tool.<xref rid="ehf212027-bib-0033" ref-type="ref">33</xref> This tool also includes an assessment of financial strain placed on the caregiver. This is an important question, as patients within the last 6&#x02009;months of life are potentially entitled to financial support in some countries.</p></sec><sec id="ehf212027-sec-0010"><title>Symptoms</title><p>Assessing on&#x02010;going symptoms should also form part of an assessment of potential PC needs in HF patients nearing end&#x02010;of&#x02010;life. HF trials tend to focus on the symptoms of dyspnoea, fatigue, and oedema. However, it has recently been shown that patients with HF can develop a multitude of other symptoms including pain, anxiety, low mood, constipation, anorexia, nausea, insomnia, and persistent cough.<xref rid="ehf212027-bib-0034" ref-type="ref">34</xref>, <xref rid="ehf212027-bib-0035" ref-type="ref">35</xref> There are recognized tools to help make an objective measurement of symptom burden but these have not been extensively evaluated in HF (although they have been in other diseases). The Edmonton Symptom Assessment System (ESAS)<xref rid="ehf212027-bib-0036" ref-type="ref">36</xref> has been validated in cancer<xref rid="ehf212027-bib-0037" ref-type="ref">37</xref>, <xref rid="ehf212027-bib-0038" ref-type="ref">38</xref> and has previously been used in a study of patients with HF.<xref rid="ehf212027-bib-0039" ref-type="ref">39</xref> Scrutiny of the content of the ESAS and this prior study suggest that it is able to quantify many of the symptoms experienced in HF.</p></sec><sec id="ehf212027-sec-0011"><title>Mood assessment</title><p>The WHO definition of PC states that PC should identify and treat psychosocial and physical problems. Therefore, any assessment of PC needs should detail how QOL, symptom burden, and end&#x02010;of&#x02010;life care potentially affect a patient's mood. Indeed, in one RCT of PC use in lung cancer, mood assessment was used as an outcome measure. Depression, which is common in HF,<xref rid="ehf212027-bib-0040" ref-type="ref">40</xref> can affect QOL<xref rid="ehf212027-bib-0041" ref-type="ref">41</xref> and is associated with higher morbidity and mortality.<xref rid="ehf212027-bib-0042" ref-type="ref">42</xref>, <xref rid="ehf212027-bib-0043" ref-type="ref">43</xref>, <xref rid="ehf212027-bib-0044" ref-type="ref">44</xref> A validated screening questionnaire for depression is the Hospital Anxiety and Depression Scale (HADS).<xref rid="ehf212027-bib-0045" ref-type="ref">45</xref> This has been used in a variety of populations,<xref rid="ehf212027-bib-0046" ref-type="ref">46</xref> and is validated in HF.<xref rid="ehf212027-bib-0047" ref-type="ref">47</xref>
</p></sec><sec id="ehf212027-sec-0012"><title>End of life care</title><p>Most patients with HF die from cardiovascular (CV) causes, the majority of which are from either worsening HF or sudden cardiac death.<xref rid="ehf212027-bib-0048" ref-type="ref">48</xref> There is some evidence that patients with more severe symptoms of HF are more likely to die from worsening HF, whereas less symptomatic patients are more likely to suffer sudden cardiac death.<xref rid="ehf212027-bib-0011" ref-type="ref">11</xref>, <xref rid="ehf212027-bib-0049" ref-type="ref">49</xref> Not every patient with HF who dies will have unmet palliative needs, e.g. those who die from sudden unexpected cardiac death with little functional limitation. However, patients with progressive HF may benefit from palliative intervention, and how these individuals are best identified is currently unknown.</p><p>The majority of HF patients currently die in hospital. Place of death was recorded in the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial with more than 50% of patients dying in hospital. Among those who died out of hospital, the mode of death was most likely to be sudden.<xref rid="ehf212027-bib-0050" ref-type="ref">50</xref> These findings were similar to those of the Sudden Cardiac Death in Heart Failure Trial (SCD&#x02010;HeFT) where 58% of patients died in hospital, 29% died at home, and 7% in an extended care facility.<xref rid="ehf212027-bib-0051" ref-type="ref">51</xref> Although these clinical trials are informative, they included selected populations and are not representative of &#x02018;real world&#x02019; patients with HF. A recent analysis of data from death certificates from England and Wales reported that over 60% of patients dying from HF died in hospital and &#x0003c;20% died at home.<xref rid="ehf212027-bib-0052" ref-type="ref">52</xref> However, HF is under&#x02010;reported on death certificates,<xref rid="ehf212027-bib-0053" ref-type="ref">53</xref>, <xref rid="ehf212027-bib-0054" ref-type="ref">54</xref> and this finding may not reflect the true experience of patients with HF. Preferred place of death when recovery seemed unlikely was described in a study of 80 patients hospitalized with HF which reported that 50% wished to be cared for at home, 40% wished to remain in hospital, and 10% were unsure.<xref rid="ehf212027-bib-0055" ref-type="ref">55</xref> Data comparing preferred place of death to actual place of death are lacking in an unselected cohort of patients with HF.</p><p>Patient preference for EOL care has been identified as a priority for research into PC need in HF.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref>, <xref rid="ehf212027-bib-0056" ref-type="ref">56</xref> Previous studies suggest that patients often change their mind about preferred place of death, and there is also poor agreement with their caregiver on this issue.<xref rid="ehf212027-bib-0057" ref-type="ref">57</xref> Patients also change their mind about resuscitation status.<xref rid="ehf212027-bib-0058" ref-type="ref">58</xref>, <xref rid="ehf212027-bib-0059" ref-type="ref">59</xref> A recent study showed that HF patients were willing to discuss EOL issues and that patients were willing to trade QOL for length of life,<xref rid="ehf212027-bib-0060" ref-type="ref">60</xref> which is contrary to previous studies.<xref rid="ehf212027-bib-0061" ref-type="ref">61</xref>, <xref rid="ehf212027-bib-0062" ref-type="ref">62</xref> Although these studies are informative, they are based on selected cohorts of patients.</p><p>Any EOL assessment should not only assess preference for and actual place of death, but also the patient and caregiver experience of dying, wherever that occurs. The Views of Informal Carers for the Evaluation of Services (VOICES) postal questionnaire has been designed to evaluate relative's experience of EOL care of the patients in the last few months of life.<xref rid="ehf212027-bib-0063" ref-type="ref">63</xref> This questionnaire has been validated, and a recent review by the United Kingdom's Department of Health has identified this as an appropriate measurement tool and the tool of choice in a survey of EOL care.<xref rid="ehf212027-bib-0064" ref-type="ref">64</xref>
</p></sec><sec id="ehf212027-sec-0013"><title>Identification of patients with palliative care needs</title><p>Before an RCT of PC use in HF can be planned, there is a need to further explore how patients with PC needs can be identified and which require the additional services of a specialist PC service. HF Guidelines suggest using the following factors to identify patients with HF and PC needs: frequent admission to hospital with decompensated HF; weight loss and cachexia; the need for frequent or on&#x02010;going intravenous therapy; chronic poor QOL with New York Heart Association (NYHA) class IV symptoms; and a clinical judgement that the patient is close to the EOL.<xref rid="ehf212027-bib-0007" ref-type="ref">7</xref>, <xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> However, predicting prognosis is notoriously difficult and is recognized as a barrier to PC referral in HF.<xref rid="ehf212027-bib-0065" ref-type="ref">65</xref> A number of prognostic models have been described from various HF cohorts.<xref rid="ehf212027-bib-0066" ref-type="ref">66</xref> Unfortunately, most models were developed in chronic ambulatory populations (as opposed to acutely hospitalized patients) and many were based on patients not receiving contemporary pharmacotherapy, or did not include important prognostic factors such as renal function, B&#x02010;type natriuretic peptide (BNP)<xref rid="ehf212027-bib-0067" ref-type="ref">67</xref> (or NT pro BNP) or troponin.<xref rid="ehf212027-bib-0068" ref-type="ref">68</xref>, <xref rid="ehf212027-bib-0069" ref-type="ref">69</xref> Use of prognostic models has been suggested as a way of identifying HF patients who are approaching EOL.<xref rid="ehf212027-bib-0070" ref-type="ref">70</xref> However, while these models may predict death, there is no evidence to suggest that prognostic models correlate well with PC needs.<xref rid="ehf212027-bib-0071" ref-type="ref">71</xref> This question requires further exploration.<xref rid="ehf212027-bib-0072" ref-type="ref">72</xref>
</p><p>One approach to try and specifically identify and assess the PC needs of HF patients is to use tools currently in development for cancer patients, acknowledging that these require assessment in patients with HF. The Needs Assessment Tool (progressive disease &#x02013; cancer) (NAT&#x02010;PD&#x02010;C)<xref rid="ehf212027-bib-0073" ref-type="ref">73</xref> has been designed specifically to assess PC needs in cancer patients. It was designed based upon a literature review of needs of patients and their caregivers. This assessment is made on a single page and completed by the patient's healthcare professional. The NAT&#x02010;PD&#x02010;C has been validated in cancer patients<xref rid="ehf212027-bib-0074" ref-type="ref">74</xref>, <xref rid="ehf212027-bib-0075" ref-type="ref">75</xref> and has been adapted for use in HF with the creation of the Needs Assessment Tool Progressive Disease Heart Failure (NAT&#x02010;PD&#x02010;HF), with reliability testing and construct validation.<xref rid="ehf212027-bib-0076" ref-type="ref">76</xref> However, this tool has yet to be evaluated in a substantial cohort of patients with HF, and its value in identifying PC needs in patients with HF is as yet unconfirmed. Therefore, we will carry out these evaluations of the NAT&#x02010;PD&#x02010;HF.</p><p>Performance status has been used by PC clinicians in both clinical practice and research as an indication for the likely need for PC services.<xref rid="ehf212027-bib-0077" ref-type="ref">77</xref>, <xref rid="ehf212027-bib-0078" ref-type="ref">78</xref>, <xref rid="ehf212027-bib-0079" ref-type="ref">79</xref> The Karnofksy Performance Scale (KPS)<xref rid="ehf212027-bib-0080" ref-type="ref">80</xref> is regarded by many as the gold standard tool for use in cancer patients.<xref rid="ehf212027-bib-0077" ref-type="ref">77</xref>, <xref rid="ehf212027-bib-0078" ref-type="ref">78</xref> This instrument has been simplified and validated in the form of the Australia&#x02010;Modified Karnofksy Performance Scale (AKPS).<xref rid="ehf212027-bib-0081" ref-type="ref">81</xref> The AKPS has been developed for use in cancer, and review of it suggests that it should also provide a suitable assessment of performance status in patients with HF.</p><p>An overview of the study design and the outcome measures used are illustrated in <italic>Figure</italic>&#x000a0;<xref rid="ehf212027-fig-0001" ref-type="fig">1</xref>, Panel A.</p><fig fig-type="Figure" xml:lang="en" id="ehf212027-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Study design.</p></caption><graphic id="nlm-graphic-1" xlink:href="EHF2-2-25-g001"/></fig></sec><sec id="ehf212027-sec-0014"><title>Study protocol</title><p>This will be a 2&#x02010;year prospective observational study of near&#x02010;consecutive patients admitted to hospital with HF. An outline is described in <italic>Figure</italic>&#x000a0;<xref rid="ehf212027-fig-0002" ref-type="fig">2</xref>. Patients will be extensively characterized during their inpatient stay by collecting echocardiographic (<italic>Table</italic>&#x000a0;<xref rid="ehf212027-tbl-0001" ref-type="table-wrap">1</xref>), demographic, and physiological data, as well as a detailed past medical history. Patient symptom burden, mood, and QOL will be assessed during the index admission and repeatedly during follow up. The burden on caregivers will also be assessed. Patient preference for place of death (and actual place of death, if death occurs), as well as resuscitation preference, will be recorded. Health care utilisation will be evaluated.</p><fig fig-type="Figure" xml:lang="en" id="ehf212027-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Study protocol.</p></caption><graphic id="nlm-graphic-3" xlink:href="EHF2-2-25-g002"/></fig><table-wrap id="ehf212027-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Echocardiographic protocol and data</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Protocol</th><th rowspan="2" align="center" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Measurement</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Window</th><th align="center" valign="bottom" rowspan="1" colspan="1">Doppler</th><th align="center" valign="bottom" rowspan="1" colspan="1">2D/M&#x02010;mode</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Parasternal</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" style="padding-left:10%" align="left" valign="top" colspan="1">Long axis</td><td rowspan="2" align="left" valign="top" colspan="1">MV &#x00026; AV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1">IVSd, LVEDD, LVPWd</td><td align="left" valign="top" rowspan="1" colspan="1">LV end diastolic dimension (cm/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IVSs, LVESD, LVPWs, LVOT, LA</td><td align="left" valign="top" rowspan="1" colspan="1">LV end systolic dimension (cm/m<sup>2</sup>)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">RV inflow</td><td align="left" valign="top" rowspan="1" colspan="1">TV CW&#x02009;+&#x02009;colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Short axis</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:15%" align="left" valign="top" rowspan="1" colspan="1">Base</td><td align="left" valign="top" rowspan="1" colspan="1">AV, TV &#x00026; PV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:15%" align="left" valign="top" rowspan="1" colspan="1">MV</td><td align="left" valign="top" rowspan="1" colspan="1">MV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:15%" align="left" valign="top" rowspan="1" colspan="1">Papillary muscle</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2D endocardial &#x00026; epicardial area</td><td align="left" valign="top" rowspan="1" colspan="1">LV mass index (g/m<sup>2</sup>)</td></tr><tr style="border-bottom:solid 1px #000000"><td style="padding-left:15%" align="left" valign="top" rowspan="1" colspan="1">apex</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Apical</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="8" style="padding-left:10%" align="left" valign="top" colspan="1">4 chamber</td><td align="left" valign="top" rowspan="1" colspan="1">MV annulus TDI&#x02009;+&#x02009;LV inflow PW</td><td align="left" valign="top" rowspan="1" colspan="1">LV volume diastole&#x02009;+&#x02009;systole, LAA</td><td align="left" valign="top" rowspan="1" colspan="1">LV EF (%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MV colour flow, TV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">LV diastolic volume (ml/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">LV systolic volume (ml/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">LV stroke volume (ml)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Cardiac output (L/min)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">LV diastolic parameters (E, E/e&#x02019;, IVRT, E/A)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Left atrial volume (ml/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Valve assessment of structure and function</td></tr><tr><td rowspan="4" style="padding-left:10%" align="left" valign="top" colspan="1">2 chamber</td><td rowspan="4" align="left" valign="top" colspan="1">MV colour flow</td><td rowspan="4" align="left" valign="top" colspan="1">LV volume diastole&#x02009;+&#x02009;systole, LAA</td><td align="left" valign="top" rowspan="1" colspan="1">LV EF (%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Left atrial volume (ml/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LV diastolic volume (ml/m<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LV systolic volume (ml/m<sup>2</sup>)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">5 chamber</td><td align="left" valign="top" rowspan="1" colspan="1">AV CW&#x02009;+&#x02009;PW&#x02009;+&#x02009;IVRT, AV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Long axis</td><td align="left" valign="top" rowspan="1" colspan="1">MV colour flow</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">RV</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TAPSE, RAA</td><td align="left" valign="top" rowspan="1" colspan="1">TAPSE</td></tr><tr style="border-bottom:solid 1px #000000"><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Right atrial area (mm<sup>2</sup>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Subcostal</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">4 chamber</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">IVC &#x00026; hepatic veins</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">IVC diameter</td><td align="left" valign="top" rowspan="1" colspan="1">RVSP</td></tr></tbody></table><table-wrap-foot><fn id="ehf212027-note-0001"><p>AV, aortic valve; CW, continuous wave; E, early diastolic filling; e&#x02019;, early lengthening velocity; IVC, inferior vena cava; IVRT, isovolumic relaxation time; IVSd, intraventricular septal diastole; IVSs, intraventricular septum systole; LVEDd, left ventricular end&#x02010;diastolic dimension; LVESD, left ventricular end&#x02010;systolic dimension; LVPWd, left ventricular posterior wall diastole; LVEDs, left ventricle posterior wall systole; EF, ejection fraction; LAA, left atrial area; LV, left ventricle; MV, mitral valve; PV, pulmonary valve; PW, pulsed wave; RV, right ventricle; RVSP, right ventricular systolic pressure; TAPSE, tricuspid annular plane systolic excursion.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="ehf212027-sec-0015"><title>Patient recruitment</title><p>Near consecutive patients admitted to the Western Infirmary in Glasgow with suspected HF will be screened for inclusion in the study. HF will be defined according to the European Society of Cardiology (ESC) guidelines.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> The Western Infirmary acts as a community hospital for the North and West of the city, serving a population of about 250&#x02009;000. All patients admitted with a primary diagnosis of clinically suspected HF will be approached and asked for permission to access their medical records and to link their record through National Health Service Scotland Information Services Division (ISD), allowing identification and cause of hospital readmission and death (including place of death). Plasma BNP will be measured to aid the diagnosis of HF (and will provide prognostic information). A finger prick (12 &#x003bc;L) sample of blood will be analysed for BNP using a validated, point of care, capillary blood sample analysis (Alere HeartCheck System). Those with a BNP &#x0003c;100&#x02009;pg/mL will be excluded.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> In addition to elevated BNP, patients must meet the ESC echocardiographic criteria for the diagnosis of HF.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref>, <xref rid="ehf212027-bib-0082" ref-type="ref">82</xref> Patients with a confirmed diagnosis of HF will be invited to participate in the study, and a further sample of blood and urine will be taken and stored for later batched analysis of biomarkers, which have prognostic importance in HF. In a previous study collecting data on near&#x02010;consecutive HF admissions, we recruited almost 350 patients at the Western Infirmary over a 2&#x02010;year period.<xref rid="ehf212027-bib-0083" ref-type="ref">83</xref> and we anticipate similar recruitment in this study. Based on our earlier study, we anticipate that approximately 30% of patients will die in the first year of follow&#x02010;up and approximately 15% per year thereafter.</p><p>Inclusion and exclusion criteria are detailed in <italic>Table</italic>&#x000a0;<xref rid="ehf212027-tbl-0002" ref-type="table-wrap">2</xref>.</p><table-wrap id="ehf212027-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Inclusion/ exclusion criteria</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">Inclusion criteria</th><th align="center" valign="bottom" rowspan="1" colspan="1">Exclusion criteria</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Admitted to hospital with a primary diagnosis of acute decompensated HF</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Refusal to participate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Age &#x02265;18&#x02009;years</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Unable to provide informed consent/complete study assessments</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Fulfilling the ESC diagnostic criteria for the diagnosis of HF</td><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x025cb; Confusion/dementia</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; HF&#x02010;REF, HF&#x02010;PEF and valvular HF will be included</td><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x025cb; Learning difficulties</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x025cb; Unable to read or write English language</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">&#x025cb; Moribund</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Readmission</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Geographical reasons, not from catchment area</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Isolated cor pulmonale</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02022; Acute coronary syndrome complicated by pulmonary oedema</td></tr></tbody></table><table-wrap-foot><fn id="ehf212027-note-0002"><p>ESC, European Society of Cardiology; HF, heart failure; HF&#x02010;REF, heart failure with reduced ejection fraction; HF&#x02010;PEF, heart failure with preserved ejection fraction.</p></fn></table-wrap-foot></table-wrap></sec><sec id="ehf212027-sec-0016"><title>Patient assessment</title><p>Detailed clinical data and data used in validated models of mortality prediction in HF will be gathered during the index hospitalisation.<xref rid="ehf212027-bib-0066" ref-type="ref">66</xref> A full echocardiographic examination will be carried out according to the European Association of Echocardiography guidelines,<xref rid="ehf212027-bib-0084" ref-type="ref">84</xref> and assessment of known prognostic variables will be recorded (<italic>Table</italic>&#x000a0;<xref rid="ehf212027-tbl-0001" ref-type="table-wrap">1</xref>). Left ventricular ejection fraction will be measured using Simpson's biplane method.<xref rid="ehf212027-bib-0085" ref-type="ref">85</xref> Before discharge from hospital, patients will complete the KCCQ and SF&#x02010;12 questionnaires to assess QOL and the ESAS questionnaire to assess their current symptom burden. Mood assessment will be made with the HADS questionnaire. Patients' caregivers will be invited to complete the Zarit Burden Interview to assess caregiver burden. Performance status will be evaluated using the AKPS. The NAT&#x02010;PD&#x02010;HF will be used to assess the palliative needs of the patient. One of the investigators will also ask about preferred place of death and resuscitation preference, in a sensitive way, in patients thought to be near to death and in those who exhibit significant deterioration during follow&#x02010;up. Patients will be asked to consider their preference for place of care, specifically, patients will be asked &#x02018;If your health was to deteriorate in the future, such that you required other people to care for you, where would you prefer that care to take place?&#x02019; Patients will then be given the following options to choose from, after explaining this is a hypothetical discussion: in their own home; a nursing or care home; hospital; hospice; or undecided. Patients will then be asked to consider their preferred place of care for EOL treatment, specifically, patients will be asked &#x02018;If you were to think about the last few days of hours of life, would you have a strong opinion or preference for where that care took place?&#x02019; Patients will then be given the following options to choose from, after explaining this is a hypothetical discussion: in their own home; a nursing or care home; hospital; hospice; or undecided. Finally, patients will be asked, after an explanation of what resuscitation is, to consider their preference for resuscitation. Specifically, patients will be asked &#x02018;Do you have a strong opinion or preference to be resuscitated or not to be resuscitated in the event of a cardiac arrest&#x02019;. Patient will be asked to pick an option from &#x02018;for active resuscitation, not for resuscitation, or undecided&#x02019;. The researcher will only ask these questions where it is felt to be appropriate, in patients approaching the EOL, and only after making explicitly clear that the questions relate to research and are not for clinical purposes. While we recognize the limitations in predicting likely death in HF, our Ethics Committee does not think it appropriate that we approach all patients about this question.</p></sec><sec id="ehf212027-sec-0017"><title>Study assessments</title><p>Following discharge, patients will be reviewed at an outpatient clinic by a cardiologist, a Heart Failure Liaison Nurse (HFLN), or both, where evidence&#x02010;based therapy will be optimized in accordance with ESC guidelines.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> Patients will be invited to attend for study assessments at 4&#x02010;monthly intervals following discharge for a maximum follow&#x02010;up period of 2.5&#x02009;years. At these visits, KCCQ, SF&#x02010;12, HADS, and ESAS questionnaires will be completed, to detail any potential change in QOL, mood, and symptom burden over time. EOL preferences will also be re&#x02010;evaluated (as appropriate), including preferred place of care/death and resuscitation preference. At these study assessments, prognostic markers will be updated and the NAT&#x02010;PD&#x02010;HF will be reassessed. To ensure a complete follow&#x02010;up as possible, we will contact those unable to attend study visits by telephone and offer home visits where possible.</p></sec><sec id="ehf212027-sec-0018"><title>Follow&#x02010;up</title><p>All patients who consent will be &#x02018;flagged&#x02019; using ISD linkage, ensuring complete follow&#x02010;up (all will be followed up for a minimum of 12&#x02009;months). PC could potentially alter Healthcare utilisation.<xref rid="ehf212027-bib-0016" ref-type="ref">16</xref> Therefore, the number of hospital admissions, length of stay, cause of admission, general practitioner (GP) visits, district nurse (DN) visits, hospice admissions, HFLN visits, and prescription costs will be recorded. These data including date, cause and location of death will be available from ISD and GP records.</p><p>Relatives of deceased patients will be asked to complete the VOICES EOL postal questionnaire. Relatives will be written to and given the opportunity to opt out prior to the questionnaire being posted.</p></sec><sec id="ehf212027-sec-0019"><title>Data handling and statistical analysis</title><p>All data will be managed and analysed by the Robertson Centre for Biostatistics (University of Glasgow) and the Data and Biostatistics Centre of the UK Clinical Research Collaboration Glasgow Clinical Trials Unit (CTU). Baseline and follow&#x02010;up data (including patient and carer QOL) will be entered into a case report form and then into the study database by experienced data entry staff. All data will be stored, managed, and analysed according to CTU standard operating procedures that comply with appropriate legal and regulatory requirements. We will define patients in need of PC as those reporting a substantial reduction in QOL, marked mood disturbance, or severe symptoms (as measured by NYHA class, KCCQ, and ESAS), especially if there is associated caregiver strain (Figure&#x000a0;<xref rid="ehf212027-fig-0001" ref-type="fig">1</xref>, Panel B). We will test whether the NAT&#x02010;PD&#x02010;HF and AKPS tools (and a prognostic score derived from standard clinical assessments) identify these patients. Much of the analysis will be descriptive, using different scores and combinations of scores from the various patient&#x02010;reported outcomes to define a need for PC (Figure&#x000a0;<xref rid="ehf212027-fig-0001" ref-type="fig">1</xref>, Panel C). We will also assess temporal variations in QOL, patient symptom burden, and PC needs for the cohort as a whole and for different patient sub&#x02010;groups. The relationship between the need for PC as identified by the NAT&#x02010;PD&#x02010;HF and other clinical and QOL instruments will be analysed using logistic regression models. The relationship between baseline characteristics, QOL data, and mortality will be assessed using logistic regression and time to event analyses. The additional value of repeated QOL assessments will be evaluated using time varying covariate Cox models.</p></sec><sec id="ehf212027-sec-0020"><title>Ethical considerations</title><p>This study will be conducted according to the principles outlined in the Declaration of Helsinki.<xref rid="ehf212027-bib-0086" ref-type="ref">86</xref> The study protocol has been approved by the West of Scotland Research Ethics Committee. All participants will be given over 24 h to read the patient information letter and consider if they wish to participate before provide written consent. Patient burden and load have been considered, and patient reported outcome measures have been chosen to limit the burden placed on participants. Burden of follow&#x02010;up study visits has been reduced by offering participants home visits or providing door&#x02010;to&#x02010;door transport. Our local Ethics Committee has asked that we only ask preferred place of death in patients thought to be near to death and in those who exhibit significant deterioration during follow&#x02010;up. While we recognize the limitations in predicting likely death in HF, our Ethics Committee does not think it appropriate that we approach all patients about this question.</p></sec><sec id="ehf212027-sec-0021"><title>Discussion</title><p>Performing research in people with serious illness is difficult, with poor recruitment, and high rates of participant dropout common,<xref rid="ehf212027-bib-0087" ref-type="ref">87</xref> perhaps explaining why few studies of PC in HF have been longitudinal, quantitative, or performed in large cohorts. Barnes <italic>et al.</italic> described their experience of recruiting a large cohort of elderly patients with HF into a longitudinal study,<xref rid="ehf212027-bib-0088" ref-type="ref">88</xref> and reported such problems. They experienced difficulties with recruitment and retention of elderly patients, with only 30% of patients approached agreeing to participate. One of the main challenges they had was the reliance on a gate&#x02010;keeper to recruit participants, in their case the GP (but in other similar studies often hospital specialists).<xref rid="ehf212027-bib-0089" ref-type="ref">89</xref> They found some GPs to be over&#x02010;restrictive in recruitment, excluding potential participants for reasons outside the protocol&#x02010;specified exclusion criteria, particularly elderly patients living in care facilities. Other GPs did not utilize the exclusion criteria, and therefore ineligible patients were also approached. These factors can introduce selection bias, reducing the generalisability of results. One of the key strengths of our study is the reduction in selection bias by approaching a consecutive, and thus recruiting a relatively unselected, cohort of hospitalized patients. We will reduce the aforementioned issues by not relying on a gate&#x02010;keeper physician to recruit participants, as a member of the study team will screen all admissions for potential participants.</p><p>Another potential issue highlighted by Barnes <italic>et al.</italic> was the identification of patients with HF. They searched patient databases for the diagnostic code &#x02018;heart failure&#x02019; and combining this with a search for patients on a regular loop diuretic. Although this screening method is efficient and has the advantage of high sensitivity, specificity is likely low. The diagnosis of HF is difficult, especially HF&#x02010;PEF,<xref rid="ehf212027-bib-0090" ref-type="ref">90</xref> and usually requires the combination of clinical signs and symptoms, natriuretic peptides, and echocardiography.<xref rid="ehf212027-bib-0010" ref-type="ref">10</xref> This highlights a further strength of our study as all potential participants will be screened using natriuretic peptides and echocardiography, making the cohort one of the best described contemporary HF populations in the field of palliative care.</p><p>Participation burden has also been identified as a potential issue affecting retention of participants in any longitudinal study of patients with HF,<xref rid="ehf212027-bib-0088" ref-type="ref">88</xref> with some outcome measures, such as filling in questionnaires or attending study assessments, becoming more challenging for participants to complete as their condition progresses and their general health deteriorates. This has been considered, and measures and study design chosen to reduce participant burden as much as possible. This is one of the main aims of this study, to pilot the use of many of the outcome measures over time in a frail population, to help inform the design of a large RCT of early PC intervention in patients with HF.</p><p>The main weakness of our study is the exclusion criteria. We will exclude patients with cognitive impairment such that they are unable to provide informed consent or complete study assessments, or those unable to complete study assessments because of language or communication difficulties. Although these criteria are necessary, we will potentially exclude not only a common group of patients,<xref rid="ehf212027-bib-0091" ref-type="ref">91</xref> but those with some of the greatest needs.<xref rid="ehf212027-bib-0092" ref-type="ref">92</xref> Targeting inpatients could also result in some patients being too unwell to participate; however, we feel the strength of recruiting an unselected hospital cohort outweighs this potential weakness.</p></sec><sec id="ehf212027-sec-0022"><title>Conclusion</title><p>This study will be one of the largest assessing PC needs in a largely unselected cohort of patients admitted to hospital with HF, and will be one of the best&#x02010;described contemporary HF cohorts. We will assess the prevalence of PC needs and describe how these needs change over time, and assess whether those with PC needs can be identified. In doing, so we will provide the foundation for designing a large RCT of an early PC intervention in HF.</p></sec><sec id="ehf212027-sec-0024"><title>Conflict of interest</title><p>None declared.</p></sec><sec id="ehf212027-sec-0025"><title>Funding</title><p>This project is supported by a project grant from the British Heart Foundation; Grant number PG/13/17/30050.</p></sec></body><back><ref-list content-type="cited-references" id="ehf212027-bibl-0001"><title>References</title><ref id="ehf212027-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ehf212027-cit-0001">
<string-name>
<surname>Davies</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Hobbs</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Davis</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Kenkre</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Roalfe</surname>
<given-names>AK</given-names>
</string-name>, 
<string-name>
<surname>Hare</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Wosornu</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Lancashire</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Prevalence of left&#x02010;ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study</article-title>. <source>Lancet</source>
<year>2001</year>; <volume>358</volume>: <fpage>439</fpage>&#x02013;<lpage>444</lpage>.<pub-id pub-id-type="pmid">11513906</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ehf212027-cit-0002">
<string-name>
<surname>McDonagh</surname>
<given-names>TA</given-names>
</string-name>, 
<string-name>
<surname>Morrison</surname>
<given-names>CE</given-names>
</string-name>, 
<string-name>
<surname>Lawrence</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Ford</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Tunstall&#x02010;Pedoe</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>, 
<string-name>
<surname>Dargie</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>Symptomatic and asymptomatic left&#x02010;ventricular systolic dysfunction in an urban population</article-title>. <source>Lancet</source>
<year>1997</year>; <volume>350</volume>: <fpage>829</fpage>&#x02013;<lpage>833</lpage>.<pub-id pub-id-type="pmid">9310600</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ehf212027-cit-0003">
<string-name>
<surname>MacIntyre</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Capewell</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Stewart</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Chalmers</surname>
<given-names>JW</given-names>
</string-name>, 
<string-name>
<surname>Boyd</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Finlayson</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Redpath</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Pell</surname>
<given-names>JP</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995</article-title>. <source>Circulation</source>
<year>2000</year>; <volume>102</volume>: <fpage>1126</fpage>&#x02013;<lpage>1131</lpage>.<pub-id pub-id-type="pmid">10973841</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ehf212027-cit-0004">
<string-name>
<surname>Mosterd</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Cost</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Hoes</surname>
<given-names>AW</given-names>
</string-name>, 
<string-name>
<surname>de Bruijne</surname>
<given-names>MC</given-names>
</string-name>, 
<string-name>
<surname>Deckers</surname>
<given-names>JW</given-names>
</string-name>, 
<string-name>
<surname>Hofman</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Grobbee</surname>
<given-names>DE</given-names>
</string-name>. <article-title>The prognosis of heart failure in the general population: The Rotterdam Study</article-title>. <source>Eur Heart J</source>
<year>2001</year>; <volume>22</volume>: <fpage>1318</fpage>&#x02013;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">11465964</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ehf212027-cit-0005">
<string-name>
<surname>Stewart</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>MacIntyre</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Hole</surname>
<given-names>DJ</given-names>
</string-name>, 
<string-name>
<surname>Capewell</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>More 'malignant' than cancer? Five&#x02010;year survival following a first admission for heart failure</article-title>. <source>Eur J Heart Fail</source>
<year>2001</year>; <volume>3</volume>: <fpage>315</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="pmid">11378002</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="ehf212027-cit-0006">
<article-title>World Health Organisation. World Health Organisation: definition of palliative care. 2012</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/cancer/palliative/definition/en/">http://www.who.int/cancer/palliative/definition/en/</ext-link> (accessed November 2014)</mixed-citation></ref><ref id="ehf212027-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ehf212027-cit-0007">
<string-name>
<surname>Jaarsma</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Beattie</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Ryder</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Rutten</surname>
<given-names>FH</given-names>
</string-name>, 
<string-name>
<surname>McDonagh</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Mohacsi</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Murray</surname>
<given-names>SA</given-names>
</string-name>, 
<string-name>
<surname>Grodzicki</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Bergh</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Metra</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Ekman</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Angermann</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Leventhal</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Pitsis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Anker</surname>
<given-names>SD</given-names>
</string-name>, 
<string-name>
<surname>Gavazzi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Ponikowski</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Dickstein</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Delacretaz</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Blue</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Strasser</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>J</given-names>
</string-name>. <article-title>Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology</article-title>. <source>Eur J Heart Fail</source>
<year>2009</year>; <volume>11</volume>: <fpage>433</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">19386813</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ehf212027-cit-0008">
<string-name>
<surname>Hunt</surname>
<given-names>SA</given-names>
</string-name>, 
<string-name>
<surname>Abraham</surname>
<given-names>WT</given-names>
</string-name>, 
<string-name>
<surname>Chin</surname>
<given-names>MH</given-names>
</string-name>, 
<string-name>
<surname>Feldman</surname>
<given-names>AM</given-names>
</string-name>, 
<string-name>
<surname>Francis</surname>
<given-names>GS</given-names>
</string-name>, 
<string-name>
<surname>Ganiats</surname>
<given-names>TG</given-names>
</string-name>, 
<string-name>
<surname>Jessup</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Konstam</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Mancini</surname>
<given-names>DM</given-names>
</string-name>, 
<string-name>
<surname>Michl</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Oates</surname>
<given-names>JA</given-names>
</string-name>, 
<string-name>
<surname>Rahko</surname>
<given-names>PS</given-names>
</string-name>, 
<string-name>
<surname>Silver</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Stevenson</surname>
<given-names>LW</given-names>
</string-name>, 
<string-name>
<surname>Yancy</surname>
<given-names>CW</given-names>
</string-name>, 
<string-name>
<surname>Antman</surname>
<given-names>EM</given-names>
</string-name>, 
<string-name>
<surname>Smith</surname>
<given-names>SC</given-names>, 
<suffix>Jr.</suffix>
</string-name>, 
<string-name>
<surname>Adams</surname>
<given-names>CD</given-names>
</string-name>, 
<string-name>
<surname>Anderson</surname>
<given-names>JL</given-names>
</string-name>, 
<string-name>
<surname>Faxon</surname>
<given-names>DP</given-names>
</string-name>, 
<string-name>
<surname>Fuster</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Halperin</surname>
<given-names>JL</given-names>
</string-name>, 
<string-name>
<surname>Hiratzka</surname>
<given-names>LF</given-names>
</string-name>, 
<string-name>
<surname>Jacobs</surname>
<given-names>AK</given-names>
</string-name>, 
<string-name>
<surname>Nishimura</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Ornato</surname>
<given-names>JP</given-names>
</string-name>, 
<string-name>
<surname>Page</surname>
<given-names>RL</given-names>
</string-name>, 
<string-name>
<surname>Riegel</surname>
<given-names>B</given-names>
</string-name>, <article-title>American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society</article-title>. <source>Circulation</source>
<year>2005</year>; <volume>112</volume>: <fpage>e154</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">16160202</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ehf212027-cit-0009">
<string-name>
<surname>Goodlin</surname>
<given-names>SJ</given-names>
</string-name>, 
<string-name>
<surname>Hauptman</surname>
<given-names>PJ</given-names>
</string-name>, 
<string-name>
<surname>Arnold</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Grady</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Hershberger</surname>
<given-names>RE</given-names>
</string-name>, 
<string-name>
<surname>Kutner</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Masoudi</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Spertus</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Dracup</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Cleary</surname>
<given-names>JF</given-names>
</string-name>, 
<string-name>
<surname>Medak</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Crispell</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Pina</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Stuart</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Whitney</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Rector</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Teno</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Renlund</surname>
<given-names>DG</given-names>
</string-name>. <article-title>Consensus statement: palliative and supportive care in advanced heart failure</article-title>. <source>J Card Fail</source>
<year>2004</year>; <volume>10</volume>: <fpage>200</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">15190529</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ehf212027-cit-0010">
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>, 
<string-name>
<surname>Adamopoulos</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Anker</surname>
<given-names>SD</given-names>
</string-name>, 
<string-name>
<surname>Auricchio</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Bohm</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Dickstein</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Falk</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Filippatos</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Fonseca</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Gomez&#x02010;Sanchez</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Jaarsma</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Kober</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Lip</surname>
<given-names>GY</given-names>
</string-name>, 
<string-name>
<surname>Maggioni</surname>
<given-names>AP</given-names>
</string-name>, 
<string-name>
<surname>Parkhomenko</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Pieske</surname>
<given-names>BM</given-names>
</string-name>, 
<string-name>
<surname>Popescu</surname>
<given-names>BA</given-names>
</string-name>, 
<string-name>
<surname>Ronnevik</surname>
<given-names>PK</given-names>
</string-name>, 
<string-name>
<surname>Rutten</surname>
<given-names>FH</given-names>
</string-name>, 
<string-name>
<surname>Schwitter</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Seferovic</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Stepinska</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Trindade</surname>
<given-names>PT</given-names>
</string-name>, 
<string-name>
<surname>Voors</surname>
<given-names>AA</given-names>
</string-name>, 
<string-name>
<surname>Zannad</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Zeiher</surname>
<given-names>A</given-names>
</string-name>. <article-title>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC</article-title>. <source>Eur Heart J</source>
<year>2012</year>; <volume>33</volume>: <fpage>1787</fpage>&#x02013;<lpage>1847</lpage>.<pub-id pub-id-type="pmid">22611136</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ehf212027-cit-0011">
<collab collab-type="authors">MERIT&#x02010;HF Study Group</collab>
. <article-title>Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT&#x02010;HF)</article-title>. <source>Lancet</source>
<year>1999</year>; <volume>353</volume>: <fpage>2001</fpage>&#x02013;<lpage>2007</lpage>.<pub-id pub-id-type="pmid">10376614</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ehf212027-cit-0012">
<string-name>
<surname>Barclay</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Momen</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Case&#x02010;Upton</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Kuhn</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Smith</surname>
<given-names>E</given-names>
</string-name>. <article-title>End&#x02010;of&#x02010;life care conversations with heart failure patients: a systematic literature review and narrative synthesis</article-title>. <source>The British Journal of General Practice : The Journal of the Royal College of General Practitioners</source>
<year>2011</year>; <volume>61</volume>: <fpage>e49</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">21401993</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ehf212027-cit-0013">
<string-name>
<surname>Low</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Pattenden</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Candy</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Beattie</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Jones</surname>
<given-names>L</given-names>
</string-name>. <article-title>Palliative care in advanced heart failure: an international review of the perspectives of recipients and health professionals on care provision</article-title>. <source>J Card Fail</source>
<year>2011</year>; <volume>17</volume>: <fpage>231</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">21362532</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ehf212027-cit-0014">
<string-name>
<surname>Owan</surname>
<given-names>TE</given-names>
</string-name>, 
<string-name>
<surname>Hodge</surname>
<given-names>DO</given-names>
</string-name>, 
<string-name>
<surname>Herges</surname>
<given-names>RM</given-names>
</string-name>, 
<string-name>
<surname>Jacobsen</surname>
<given-names>SJ</given-names>
</string-name>, 
<string-name>
<surname>Roger</surname>
<given-names>VL</given-names>
</string-name>, 
<string-name>
<surname>Redfield</surname>
<given-names>MM</given-names>
</string-name>. <article-title>Trends in prevalence and outcome of heart failure with preserved ejection fraction</article-title>. <source>N Engl J Med</source>
<year>2006</year>; <volume>355</volume>: <fpage>251</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">16855265</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ehf212027-cit-0015">
<string-name>
<surname>Bhatia</surname>
<given-names>RS</given-names>
</string-name>, 
<string-name>
<surname>Tu</surname>
<given-names>JV</given-names>
</string-name>, 
<string-name>
<surname>Lee</surname>
<given-names>DS</given-names>
</string-name>, 
<string-name>
<surname>Austin</surname>
<given-names>PC</given-names>
</string-name>, 
<string-name>
<surname>Fang</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Haouzi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Gong</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Liu</surname>
<given-names>PP</given-names>
</string-name>. <article-title>Outcome of heart failure with preserved ejection fraction in a population&#x02010;based study</article-title>. <source>N Engl J Med</source>
<year>2006</year>; <volume>355</volume>: <fpage>260</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">16855266</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ehf212027-cit-0016">
<string-name>
<surname>Temel</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Greer</surname>
<given-names>JA</given-names>
</string-name>, 
<string-name>
<surname>Muzikansky</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Gallagher</surname>
<given-names>ER</given-names>
</string-name>, 
<string-name>
<surname>Admane</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Jackson</surname>
<given-names>VA</given-names>
</string-name>, 
<string-name>
<surname>Dahlin</surname>
<given-names>CM</given-names>
</string-name>, 
<string-name>
<surname>Blinderman</surname>
<given-names>CD</given-names>
</string-name>, 
<string-name>
<surname>Jacobsen</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Pirl</surname>
<given-names>WF</given-names>
</string-name>, 
<string-name>
<surname>Billings</surname>
<given-names>JA</given-names>
</string-name>, 
<string-name>
<surname>Lynch</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Early palliative care for patients with metastatic non&#x02010;small&#x02010;cell lung cancer</article-title>. <source>N Engl J Med</source>
<year>2010</year>; <volume>363</volume>: <fpage>733</fpage>&#x02013;<lpage>742</lpage>.<pub-id pub-id-type="pmid">20818875</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ehf212027-cit-0017">
<string-name>
<surname>Zimmermann</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Swami</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Krzyzanowska</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Hannon</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Leighl</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Oza</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Moore</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Rydall</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Rodin</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Tannock</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Donner</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Lo</surname>
<given-names>C</given-names>
</string-name>. <article-title>Early palliative care for patients with advanced cancer: a cluster&#x02010;randomised controlled trial</article-title>. <source>Lancet</source>
<year>2014</year>; <volume>383</volume>: <fpage>1721</fpage>&#x02013;<lpage>1730</lpage>.<pub-id pub-id-type="pmid">24559581</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ehf212027-cit-0018">
<string-name>
<surname>Brumley</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Enguidanos</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Jamison</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Seitz</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Morgenstern</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Saito</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>McIlwane</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Hillary</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Gonzalez</surname>
<given-names>J</given-names>
</string-name>. <article-title>Increased satisfaction with care and lower costs: results of a randomized trial of in&#x02010;home palliative care</article-title>. <source>J Am Geriatr Soc</source>
<year>2007</year>; <volume>55</volume>: <fpage>993</fpage>&#x02013;<lpage>1000</lpage>.<pub-id pub-id-type="pmid">17608870</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ehf212027-cit-0019">
<string-name>
<surname>Brannstrom</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Boman</surname>
<given-names>K</given-names>
</string-name>. <article-title>Effects of person&#x02010;centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study</article-title>. <source>Eur J Heart Fail</source>
<year>2014</year>; <volume>16</volume>: <fpage>1142</fpage>&#x02013;<lpage>1151</lpage>.<pub-id pub-id-type="pmid">25159126</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ehf212027-cit-0020">
<string-name>
<surname>Berry</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>J</given-names>
</string-name>. <article-title>A review of quality&#x02010;of&#x02010;life evaluations in patients with congestive heart failure</article-title>. <source>Pharmacoeconomics</source>
<year>1999</year>; <volume>16</volume>: <fpage>247</fpage>&#x02013;<lpage>271</lpage>.<pub-id pub-id-type="pmid">10558038</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ehf212027-cit-0021">
<string-name>
<surname>Green</surname>
<given-names>CP</given-names>
</string-name>, 
<string-name>
<surname>Porter</surname>
<given-names>CB</given-names>
</string-name>, 
<string-name>
<surname>Bresnahan</surname>
<given-names>DR</given-names>
</string-name>, 
<string-name>
<surname>Spertus</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure</article-title>. <source>J Am Coll Cardiol</source>
<year>2000</year>; <volume>35</volume>: <fpage>1245</fpage>&#x02013;<lpage>1255</lpage>.<pub-id pub-id-type="pmid">10758967</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ehf212027-cit-0022">
<string-name>
<surname>Soto</surname>
<given-names>GE</given-names>
</string-name>, 
<string-name>
<surname>Jones</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Weintraub</surname>
<given-names>WS</given-names>
</string-name>, 
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>, 
<string-name>
<surname>Spertus</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Prognostic value of health status in patients with heart failure after acute myocardial infarction</article-title>. <source>Circulation</source>
<year>2004</year>; <volume>110</volume>: <fpage>546</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">15262843</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ehf212027-cit-0023">
<string-name>
<surname>Spertus</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Peterson</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Conard</surname>
<given-names>MW</given-names>
</string-name>, 
<string-name>
<surname>Heidenreich</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>, 
<string-name>
<surname>Jones</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>McCullough</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Pina</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Tooley</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Weintraub</surname>
<given-names>WS</given-names>
</string-name>, 
<string-name>
<surname>Rumsfeld</surname>
<given-names>JS</given-names>
</string-name>, <article-title>Cardiovascular outcomes research consortium monitoring clinical changes in patients with heart failure: a comparison of methods</article-title>. <source>Am Heart J</source>
<year>2005</year>; <volume>150</volume>: <fpage>707</fpage>&#x02013;<lpage>715</lpage>.<pub-id pub-id-type="pmid">16209970</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ehf212027-cit-0024">
<string-name>
<surname>Heidenreich</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Spertus</surname>
<given-names>JA</given-names>
</string-name>, 
<string-name>
<surname>Jones</surname>
<given-names>PG</given-names>
</string-name>, 
<string-name>
<surname>Weintraub</surname>
<given-names>WS</given-names>
</string-name>, 
<string-name>
<surname>Rumsfeld</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Rathore</surname>
<given-names>SS</given-names>
</string-name>, 
<string-name>
<surname>Peterson</surname>
<given-names>ED</given-names>
</string-name>, 
<string-name>
<surname>Masoudi</surname>
<given-names>FA</given-names>
</string-name>, 
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>, 
<string-name>
<surname>Havranek</surname>
<given-names>EP</given-names>
</string-name>, 
<string-name>
<surname>Conard</surname>
<given-names>MW</given-names>
</string-name>, 
<string-name>
<surname>Williams</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Cardiovascular outcomes research consortium. Health status identifies heart failure outpatients at risk for hospitalization or death</article-title>. <source>J Am Coll Cardiol</source>
<year>2006</year>; <volume>47</volume>: <fpage>752</fpage>&#x02013;<lpage>756</lpage>.<pub-id pub-id-type="pmid">16487840</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ehf212027-cit-0025">
<string-name>
<surname>Kosiborod</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Soto</surname>
<given-names>GE</given-names>
</string-name>, 
<string-name>
<surname>Jones</surname>
<given-names>PG</given-names>
</string-name>, 
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>, 
<string-name>
<surname>Weintraub</surname>
<given-names>WS</given-names>
</string-name>, 
<string-name>
<surname>Deedwania</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Spertus</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Identifying heart failure patients at high risk for near&#x02010;term cardiovascular events with serial health status assessments</article-title>. <source>Circulation</source>
<year>2007</year>; <volume>115</volume>: <fpage>1975</fpage>&#x02013;<lpage>1981</lpage>.<pub-id pub-id-type="pmid">17420346</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ehf212027-cit-0026">
<string-name>
<surname>Ware</surname>
<given-names>JE</given-names>
<suffix>Jr</suffix>
</string-name>, 
<string-name>
<surname>Sherbourne</surname>
<given-names>CD</given-names>
</string-name>. <article-title>The MOS 36&#x02010;item short&#x02010;form health survey (SF&#x02010;36) I. Conceptual framework and item selection</article-title>. <source>Med Care</source>
<year>1992</year>; <volume>30</volume>: <fpage>473</fpage>&#x02013;<lpage>483</lpage>.<pub-id pub-id-type="pmid">1593914</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ehf212027-cit-0027">
<string-name>
<surname>Jenkinson</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Coulter</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Wright</surname>
<given-names>L</given-names>
</string-name>. <article-title>Short form 36 (SF36) health survey questionnaire: normative data for adults of working age</article-title>. <source>BMJ</source>
<year>1993</year>; <volume>306</volume>: <fpage>1437</fpage>&#x02013;<lpage>1440</lpage>.<pub-id pub-id-type="pmid">8518639</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ehf212027-cit-0028">
<string-name>
<surname>Ware</surname>
<given-names>JE</given-names>
<suffix>Jr</suffix>
</string-name>, 
<string-name>
<surname>Bayliss</surname>
<given-names>MS</given-names>
</string-name>, 
<string-name>
<surname>Rogers</surname>
<given-names>WH</given-names>
</string-name>, 
<string-name>
<surname>Kosinski</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Tarlov</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Differences in 4&#x02010;year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee&#x02010;for&#x02010;service systems. Results from the Medical Outcomes Study</article-title>. <source>JAMA</source>
<year>1996</year>; <volume>276</volume>: <fpage>1039</fpage>&#x02013;<lpage>1047</lpage>.<pub-id pub-id-type="pmid">8847764</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ehf212027-cit-0029">
<string-name>
<surname>Ware</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</string-name>, 
<string-name>
<surname>Kosinski</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Keller</surname>
<given-names>SD</given-names>
</string-name>. <article-title>A 12&#x02010;Item Short&#x02010;Form Health Survey: construction of scales and preliminary tests of reliability and validity</article-title>. <source>Med Care</source>
<year>1996</year>; <volume>34</volume>: <fpage>220</fpage>&#x02013;<lpage>233</lpage>.<pub-id pub-id-type="pmid">8628042</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ehf212027-cit-0030">
<string-name>
<surname>Jenkinson</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Layte</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Jenkinson</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Lawrence</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Petersen</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Paice</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Stradling</surname>
<given-names>J</given-names>
</string-name>. <article-title>A shorter form health survey: can the SF&#x02010;12 replicate results from the SF&#x02010;36 in longitudinal studies?</article-title>
<source>J Public Health Med</source>
<year>1997</year>; <volume>19</volume>: <fpage>179</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">9243433</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ehf212027-cit-0031">
<string-name>
<surname>Iqbal</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Francis</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Reid</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Murray</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Denvir</surname>
<given-names>M</given-names>
</string-name>. <article-title>Quality of life in patients with chronic heart failure and their carers: a 3&#x02010;year follow&#x02010;up study assessing hospitalization and mortality</article-title>. <source>Eur J Heart Fail</source>
<year>2010</year>; <volume>12</volume>: <fpage>1002</fpage>&#x02013;<lpage>1008</lpage>.<pub-id pub-id-type="pmid">20615920</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ehf212027-cit-0032">
<string-name>
<surname>Zarit</surname>
<given-names>SH</given-names>
</string-name>, 
<string-name>
<surname>Reever</surname>
<given-names>KE</given-names>
</string-name>, 
<string-name>
<surname>Bach&#x02010;Peterson</surname>
<given-names>J</given-names>
</string-name>. <article-title>Relatives of the impaired elderly: correlates of feelings of burden</article-title>. <source>Gerontologist</source>
<year>1980</year>; <volume>20</volume>: <fpage>649</fpage>&#x02013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">7203086</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ehf212027-cit-0033">
<string-name>
<surname>Whalen</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Bucholz</surname>
<given-names>SW</given-names>
</string-name>. <article-title>The Reliability, Validity and Feasibility of Tools Used to Screen for Caregiver Burden: a Systematic Review</article-title>. <source>JBI Lib Syst Rev</source>
<year>2009</year>; <volume>7</volume>: <fpage>1372</fpage>&#x02013;<lpage>1429</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ehf212027-cit-0034">
<string-name>
<surname>Nordgren</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Sorensen</surname>
<given-names>S</given-names>
</string-name>. <article-title>Symptoms experienced in the last six months of life in patients with end&#x02010;stage heart failure</article-title>. <source>European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology</source>
<year>2003</year>; <volume>2</volume>: <fpage>213</fpage>&#x02013;<lpage>217</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ehf212027-cit-0035">
<string-name>
<surname>Janssen</surname>
<given-names>DJ</given-names>
</string-name>, 
<string-name>
<surname>Spruit</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Wouters</surname>
<given-names>EF</given-names>
</string-name>, 
<string-name>
<surname>Schols</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Daily symptom burden in end&#x02010;stage chronic organ failure: a systematic review</article-title>. <source>Palliat Med</source>
<year>2008</year>; <volume>22</volume>: <fpage>938</fpage>&#x02013;<lpage>948</lpage>.<pub-id pub-id-type="pmid">18801874</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ehf212027-cit-0036">
<string-name>
<surname>Bruera</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Kuehn</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Miller</surname>
<given-names>MJ</given-names>
</string-name>, 
<string-name>
<surname>Selmser</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Macmillan</surname>
<given-names>K</given-names>
</string-name>. <article-title>The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients</article-title>. <source>J Palliat Care</source>
<year>1991</year>; <volume>7</volume>: <fpage>6</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">1714502</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ehf212027-cit-0037">
<string-name>
<surname>Chang</surname>
<given-names>VT</given-names>
</string-name>, 
<string-name>
<surname>Hwang</surname>
<given-names>SS</given-names>
</string-name>, 
<string-name>
<surname>Feuerman</surname>
<given-names>M</given-names>
</string-name>. <article-title>Validation of the Edmonton Symptom Assessment Scale</article-title>. <source>Cancer</source>
<year>2000</year>; <volume>88</volume>: <fpage>2164</fpage>&#x02013;<lpage>2171</lpage>.<pub-id pub-id-type="pmid">10813730</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ehf212027-cit-0038">
<string-name>
<surname>Moro</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Brunelli</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Miccinesi</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Fallai</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Morino</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Piazza</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Labianca</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Ripamonti</surname>
<given-names>C</given-names>
</string-name>. <article-title>Edmonton symptom assessment scale: Italian validation in two palliative care settings</article-title>. <source>Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer</source>
<year>2006</year>; <volume>14</volume>: <fpage>30</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">15937688</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ehf212027-cit-0039">
<string-name>
<surname>Opasich</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Gualco</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>De Feo</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Barbieri</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Cioffi</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Giardini</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Majani</surname>
<given-names>G</given-names>
</string-name>. <article-title>Physical and emotional symptom burden of patients with end&#x02010;stage heart failure: what to measure, how and why</article-title>. <source>J Cardiovasc Med</source>
<year>2008</year>; <volume>9</volume>: <fpage>1104</fpage>&#x02013;<lpage>1108</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ehf212027-cit-0040">
<string-name>
<surname>Rutledge</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Reis</surname>
<given-names>VA</given-names>
</string-name>, 
<string-name>
<surname>Linke</surname>
<given-names>SE</given-names>
</string-name>, 
<string-name>
<surname>Greenberg</surname>
<given-names>BH</given-names>
</string-name>, 
<string-name>
<surname>Mills</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Depression in heart failure a meta&#x02010;analytic review of prevalence, intervention effects, and associations with clinical outcomes</article-title>. <source>J Am Coll Cardiol</source>
<year>2006</year>; <volume>48</volume>: <fpage>1527</fpage>&#x02013;<lpage>1537</lpage>.<pub-id pub-id-type="pmid">17045884</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ehf212027-cit-0041">
<string-name>
<surname>Dekker</surname>
<given-names>RL</given-names>
</string-name>, 
<string-name>
<surname>Lennie</surname>
<given-names>TA</given-names>
</string-name>, 
<string-name>
<surname>Albert</surname>
<given-names>NM</given-names>
</string-name>, 
<string-name>
<surname>Rayens</surname>
<given-names>MK</given-names>
</string-name>, 
<string-name>
<surname>Chung</surname>
<given-names>ML</given-names>
</string-name>, 
<string-name>
<surname>Wu</surname>
<given-names>JR</given-names>
</string-name>, 
<string-name>
<surname>Song</surname>
<given-names>EK</given-names>
</string-name>, 
<string-name>
<surname>Moser</surname>
<given-names>DK</given-names>
</string-name>. <article-title>Depressive symptom trajectory predicts 1&#x02010;year health&#x02010;related quality of life in patients with heart failure</article-title>. <source>J Card Fail</source>
<year>2011</year>; <volume>17</volume>: <fpage>755</fpage>&#x02013;<lpage>763</lpage>.<pub-id pub-id-type="pmid">21872146</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ehf212027-cit-0042">
<string-name>
<surname>Jiang</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Alexander</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Christopher</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Kuchibhatla</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Gaulden</surname>
<given-names>LH</given-names>
</string-name>, 
<string-name>
<surname>Cuffe</surname>
<given-names>MS</given-names>
</string-name>, 
<string-name>
<surname>Blazing</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Davenport</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Califf</surname>
<given-names>RM</given-names>
</string-name>, 
<string-name>
<surname>Krishnan</surname>
<given-names>RR</given-names>
</string-name>, 
<string-name>
<surname>O'Connor</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure</article-title>. <source>Arch Intern Med</source>
<year>2001</year>; <volume>161</volume>: <fpage>1849</fpage>&#x02013;<lpage>1856</lpage>.<pub-id pub-id-type="pmid">11493126</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ehf212027-cit-0043">
<string-name>
<surname>Vaccarino</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Kasl</surname>
<given-names>SV</given-names>
</string-name>, 
<string-name>
<surname>Abramson</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>. <article-title>Depressive symptoms and risk of functional decline and death in patients with heart failure</article-title>. <source>J Am Coll Cardiol</source>
<year>2001</year>;<volume>38</volume>:<fpage>199</fpage>&#x02010;<lpage>205</lpage>.<pub-id pub-id-type="pmid">11451275</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ehf212027-cit-0044">
<string-name>
<surname>Albert</surname>
<given-names>NM</given-names>
</string-name>, 
<string-name>
<surname>Fonarow</surname>
<given-names>GC</given-names>
</string-name>, 
<string-name>
<surname>Abraham</surname>
<given-names>WT</given-names>
</string-name>, 
<string-name>
<surname>Gheorghiade</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Greenberg</surname>
<given-names>BH</given-names>
</string-name>, 
<string-name>
<surname>Nunez</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>O'Connor</surname>
<given-names>CM</given-names>
</string-name>, 
<string-name>
<surname>Stough</surname>
<given-names>WG</given-names>
</string-name>, 
<string-name>
<surname>Yancy</surname>
<given-names>CW</given-names>
</string-name>, 
<string-name>
<surname>Young</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Depression and clinical outcomes in heart failure: an OPTIMIZE&#x02010;HF analysis</article-title>. <source>Am J Med</source>
<year>2009</year>; <volume>122</volume>: <fpage>366</fpage>&#x02013;<lpage>373</lpage>.<pub-id pub-id-type="pmid">19332232</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ehf212027-cit-0045">
<string-name>
<surname>Zigmond</surname>
<given-names>AS</given-names>
</string-name>, 
<string-name>
<surname>Snaith</surname>
<given-names>RP</given-names>
</string-name>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source>
<year>1983</year>; <volume>67</volume>: <fpage>361</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">6880820</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ehf212027-cit-0046">
<string-name>
<surname>Bjelland</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Dahl</surname>
<given-names>AA</given-names>
</string-name>, 
<string-name>
<surname>Haug</surname>
<given-names>TT</given-names>
</string-name>, 
<string-name>
<surname>Neckelmann</surname>
<given-names>D</given-names>
</string-name>. <article-title>The validity of the Hospital Anxiety and Depression Scale. An updated literature review</article-title>. <source>J Psychosom Res</source>
<year>2002</year>; <volume>52</volume>: <fpage>69</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">11832252</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ehf212027-cit-0047">
<string-name>
<surname>Haworth</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Moniz&#x02010;Cook</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Clark</surname>
<given-names>AL</given-names>
</string-name>, 
<string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Cleland</surname>
<given-names>JG</given-names>
</string-name>. <article-title>An evaluation of two self&#x02010;report screening measures for mood in an out&#x02010;patient chronic heart failure population</article-title>. <source>Int J Geriatr Psychiatry</source>
<year>2007</year>; <volume>22</volume>: <fpage>1147</fpage>&#x02013;<lpage>1153</lpage>.<pub-id pub-id-type="pmid">17457953</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ehf212027-cit-0048">
<string-name>
<surname>Carson</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Anand</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>O'Connor</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Jaski</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Steinberg</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Lwin</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Lindenfeld</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Ghali</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Barnet</surname>
<given-names>JH</given-names>
</string-name>, 
<string-name>
<surname>Feldman</surname>
<given-names>AM</given-names>
</string-name>, 
<string-name>
<surname>Bristow</surname>
<given-names>MR</given-names>
</string-name>. <article-title>Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial</article-title>. <source>J Am Coll Cardiol</source>
<year>2005</year>; <volume>46</volume>: <fpage>2329</fpage>&#x02013;<lpage>2334</lpage>.<pub-id pub-id-type="pmid">16360067</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="ehf212027-cit-0049">
<string-name>
<surname>O'Connor</surname>
<given-names>CM</given-names>
</string-name>, 
<string-name>
<surname>Miller</surname>
<given-names>AB</given-names>
</string-name>, 
<string-name>
<surname>Blair</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Konstam</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Wedge</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Bahit</surname>
<given-names>MC</given-names>
</string-name>, 
<string-name>
<surname>Carson</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Haass</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Hauptman</surname>
<given-names>PJ</given-names>
</string-name>, 
<string-name>
<surname>Metra</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Oren</surname>
<given-names>RM</given-names>
</string-name>, 
<string-name>
<surname>Patten</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Pina</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Roth</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Sackner&#x02010;Bernstein</surname>
<given-names>JD</given-names>
</string-name>, 
<string-name>
<surname>Traver</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Cook</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Gheorghiade</surname>
<given-names>M</given-names>
</string-name>, <article-title>Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program</article-title>. <source>Am Heart J</source>
<year>2010</year>; <volume>159</volume>: <fpage>841</fpage>&#x02013;<lpage>849</lpage> e841.<pub-id pub-id-type="pmid">20435194</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="ehf212027-cit-0050">
<string-name>
<surname>Poole&#x02010;Wilson</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Uretsky</surname>
<given-names>BF</given-names>
</string-name>, 
<string-name>
<surname>Thygesen</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Cleland</surname>
<given-names>JG</given-names>
</string-name>, 
<string-name>
<surname>Massie</surname>
<given-names>BM</given-names>
</string-name>, 
<string-name>
<surname>Ryden</surname>
<given-names>L</given-names>
</string-name>, <collab collab-type="authors">Atlas Study Group</collab>
. <article-title>Mode of death in heart failure: findings from the ATLAS trial</article-title>. <source>Heart</source>
<year>2003</year>; <volume>89</volume>: <fpage>42</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">12482789</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="ehf212027-cit-0051">
<string-name>
<surname>Olshansky</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Wood</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Hellkamp</surname>
<given-names>AS</given-names>
</string-name>, 
<string-name>
<surname>Poole</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Anderson</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Johnson</surname>
<given-names>GW</given-names>
</string-name>, 
<string-name>
<surname>Boineau</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Domanski</surname>
<given-names>MJ</given-names>
</string-name>, 
<string-name>
<surname>Mark</surname>
<given-names>DB</given-names>
</string-name>, 
<string-name>
<surname>Lee</surname>
<given-names>KL</given-names>
</string-name>, 
<string-name>
<surname>Bardy</surname>
<given-names>GH</given-names>
</string-name>, <article-title>SCD&#x02010;HeFT Investigators. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD&#x02010;HeFT)</article-title>. <source>Am Heart J</source>
<year>2007</year>; <volume>153</volume>: <fpage>1089</fpage>&#x02013;<lpage>1094</lpage>.<pub-id pub-id-type="pmid">17540216</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="ehf212027-cit-0052">
<string-name>
<surname>Laribi</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Aouba</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Nikolaou</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Lassus</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Cohen&#x02010;Solal</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Plaisance</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Pavillon</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Jois</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Fonarow</surname>
<given-names>GC</given-names>
</string-name>, 
<string-name>
<surname>Jougla</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Mebazaa</surname>
<given-names>A</given-names>
</string-name>, <article-title>GREAT network Trends in death attributed to heart failure over the past two decades in Europe</article-title>. <source>Eur J Heart Fail</source>
<year>2012</year>; <volume>14</volume>: <fpage>234</fpage>&#x02013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">22237388</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="ehf212027-cit-0053">
<string-name>
<surname>Murdoch</surname>
<given-names>DR</given-names>
</string-name>, 
<string-name>
<surname>Love</surname>
<given-names>MP</given-names>
</string-name>, 
<string-name>
<surname>Robb</surname>
<given-names>SD</given-names>
</string-name>, 
<string-name>
<surname>McDonagh</surname>
<given-names>TA</given-names>
</string-name>, 
<string-name>
<surname>Davie</surname>
<given-names>AP</given-names>
</string-name>, 
<string-name>
<surname>Ford</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Capewell</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Morrison</surname>
<given-names>CE</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979&#x02010;1992</article-title>. <source>Eur Heart J</source>
<year>1998</year>; <volume>19</volume>: <fpage>1829</fpage>&#x02013;<lpage>1835</lpage>.<pub-id pub-id-type="pmid">9886726</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="ehf212027-cit-0054">
<string-name>
<surname>Engelfriet</surname>
<given-names>PM</given-names>
</string-name>, 
<string-name>
<surname>Hoogenveen</surname>
<given-names>RT</given-names>
</string-name>, 
<string-name>
<surname>Boshuizen</surname>
<given-names>HC</given-names>
</string-name>, 
<string-name>
<surname>van Baal</surname>
<given-names>PH</given-names>
</string-name>. <article-title>To die with or from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics?</article-title>
<source>Eur J Heart Fail</source>
<year>2011</year>; <volume>13</volume>: <fpage>377</fpage>&#x02013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">21216785</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="ehf212027-cit-0055">
<string-name>
<surname>Formiga</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Chivite</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Ortega</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Casas</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Ramon</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Pujol</surname>
<given-names>R</given-names>
</string-name>. <article-title>End&#x02010;of&#x02010;life preferences in elderly patients admitted for heart failure</article-title>. <source>QJM</source>
<year>2004</year>; <volume>97</volume>: <fpage>803</fpage>&#x02013;<lpage>808</lpage>.<pub-id pub-id-type="pmid">15569812</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="ehf212027-cit-0056">
<string-name>
<surname>Metra</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Ponikowski</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Dickstein</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>, 
<string-name>
<surname>Gavazzi</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Bergh</surname>
<given-names>CH</given-names>
</string-name>, 
<string-name>
<surname>Fraser</surname>
<given-names>AG</given-names>
</string-name>, 
<string-name>
<surname>Jaarsma</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Pitsis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Mohacsi</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Bohm</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Anker</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Dargie</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Brutsaert</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Komajda</surname>
<given-names>M</given-names>
</string-name>, <article-title>Heart Failure Association of the European Society of Cardiology Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology</article-title>. <source>Eur J Heart Fail</source>
<year>2007</year>; <volume>9</volume>: <fpage>684</fpage>&#x02013;<lpage>694</lpage>.<pub-id pub-id-type="pmid">17481947</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="ehf212027-cit-0057">
<string-name>
<surname>Agar</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>DC</given-names>
</string-name>, 
<string-name>
<surname>Shelby&#x02010;James</surname>
<given-names>TM</given-names>
</string-name>, 
<string-name>
<surname>Plummer</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Sanderson</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Abernethy</surname>
<given-names>AP</given-names>
</string-name>. <article-title>Preference for place of care and place of death in palliative care: are these different questions?</article-title>
<source>Palliat Med</source>
<year>2008</year>; <volume>22</volume>: <fpage>787</fpage>&#x02013;<lpage>795</lpage>.<pub-id pub-id-type="pmid">18755830</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="ehf212027-cit-0058">
<string-name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</string-name>, 
<string-name>
<surname>Phillips</surname>
<given-names>RS</given-names>
</string-name>, 
<string-name>
<surname>Hamel</surname>
<given-names>MB</given-names>
</string-name>, 
<string-name>
<surname>Teno</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Bellamy</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Broste</surname>
<given-names>SK</given-names>
</string-name>, 
<string-name>
<surname>Califf</surname>
<given-names>RM</given-names>
</string-name>, 
<string-name>
<surname>Vidaillet</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Davis</surname>
<given-names>RB</given-names>
</string-name>, 
<string-name>
<surname>Muhlbaier</surname>
<given-names>LH</given-names>
</string-name>, 
<string-name>
<surname>Connors</surname>
<given-names>AF</given-names>
<suffix>Jr</suffix>
</string-name>, 
<string-name>
<surname>Lynn</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Goldman</surname>
<given-names>L</given-names>
</string-name>. <article-title>Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments</article-title>. <source>Circulation</source>
<year>1998</year>; <volume>98</volume>: <fpage>648</fpage>&#x02013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">9715857</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="ehf212027-cit-0059">
<string-name>
<surname>Janssen</surname>
<given-names>DJ</given-names>
</string-name>, 
<string-name>
<surname>Spruit</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Schols</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Cox</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Nawrot</surname>
<given-names>TS</given-names>
</string-name>, 
<string-name>
<surname>Curtis</surname>
<given-names>JR</given-names>
</string-name>, 
<string-name>
<surname>Wouters</surname>
<given-names>EF</given-names>
</string-name>. <article-title>Predicting changes in preferences for life&#x02010;sustaining treatment among patients with advanced chronic organ failure</article-title>. <source>Chest</source>
<year>2012</year>; <volume>141</volume>: <fpage>1251</fpage>&#x02013;<lpage>1259</lpage>.<pub-id pub-id-type="pmid">22016488</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="ehf212027-cit-0060">
<string-name>
<surname>Brunner&#x02010;La Rocca</surname>
<given-names>HP</given-names>
</string-name>, 
<string-name>
<surname>Rickenbacher</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Muzzarelli</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Schindler</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Maeder</surname>
<given-names>MT</given-names>
</string-name>, 
<string-name>
<surname>Jeker</surname>
<given-names>U</given-names>
</string-name>, 
<string-name>
<surname>Kiowski</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Leventhal</surname>
<given-names>ME</given-names>
</string-name>, 
<string-name>
<surname>Pfister</surname>
<given-names>O</given-names>
</string-name>, 
<string-name>
<surname>Osswald</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Pfisterer</surname>
<given-names>ME</given-names>
</string-name>, 
<string-name>
<surname>Rickli</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Investigators</surname>
<given-names>T&#x02010;C</given-names>
</string-name>. <article-title>End&#x02010;of&#x02010;life preferences of elderly patients with chronic heart failure</article-title>. <source>Eur Heart J</source>
<year>2012</year>; <volume>33</volume>: <fpage>752</fpage>&#x02013;<lpage>759</lpage>.<pub-id pub-id-type="pmid">22067089</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="ehf212027-cit-0061">
<string-name>
<surname>Rector</surname>
<given-names>TS</given-names>
</string-name>, 
<string-name>
<surname>Tschumperlin</surname>
<given-names>LK</given-names>
</string-name>, 
<string-name>
<surname>Kubo</surname>
<given-names>SH</given-names>
</string-name>, 
<string-name>
<surname>Bank</surname>
<given-names>AJ</given-names>
</string-name>, 
<string-name>
<surname>Francis</surname>
<given-names>GS</given-names>
</string-name>, 
<string-name>
<surname>McDonald</surname>
<given-names>KM</given-names>
</string-name>, 
<string-name>
<surname>Keeler</surname>
<given-names>CA</given-names>
</string-name>, 
<string-name>
<surname>Silver</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Use of the Living with Heart failure Questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug&#x02010;induced death</article-title>. <source>J Card Fail</source>
<year>1995</year>; <volume>1</volume>: <fpage>201</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">9420652</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="ehf212027-cit-0062">
<string-name>
<surname>Lewis</surname>
<given-names>EF</given-names>
</string-name>, 
<string-name>
<surname>Johnson</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Johnson</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Collins</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Griffin</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Stevenson</surname>
<given-names>LW</given-names>
</string-name>. <article-title>Preferences for quality of life or survival expressed by patients with heart failure</article-title>. <source>The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation</source>
<year>2001</year>; <volume>20</volume>: <fpage>1016</fpage>&#x02013;<lpage>1024</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="ehf212027-cit-0063">
<string-name>
<surname>Hunt</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Shlomo</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Addington&#x02010;Hall</surname>
<given-names>J</given-names>
</string-name>. <article-title>End&#x02010;of&#x02010;life care and achieving preferences for place of death in England: results of a population&#x02010;based survey using the VOICES&#x02010;SF questionnaire</article-title>. <source>Palliat Med</source>
<year>2014</year>; <volume>28</volume>: <fpage>412</fpage>&#x02013;<lpage>421</lpage>.<pub-id pub-id-type="pmid">24292157</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0064"><label>64</label><mixed-citation publication-type="miscellaneous" id="ehf212027-cit-0064">
<collab collab-type="authors">Department of Health</collab>
: <article-title>Office for National Statistics. National Bereavement Survey (VOICES). 2011</article-title>
<underline underline-style="single">;</underline>
<ext-link ext-link-type="uri" xlink:href="http://www.ons.gov.uk/ons/rel/subnational-health1/national-bereavement-survey--voices-/2012/stb---national-bereavement-survey-2012.html">http://www.ons.gov.uk/ons/rel/subnational&#x02010;health1/national&#x02010;bereavement&#x02010;survey&#x02010;&#x02010;voices&#x02010;/2012/stb&#x02010;&#x02010;&#x02010;national&#x02010;bereavement&#x02010;survey&#x02010;2012.html</ext-link>. (November 2014)</mixed-citation></ref><ref id="ehf212027-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="ehf212027-cit-0065">
<string-name>
<surname>Hanratty</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Hibbert</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Mair</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>May</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Ward</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Capewell</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Litva</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Corcoran</surname>
<given-names>G</given-names>
</string-name>. <article-title>Doctors' perceptions of palliative care for heart failure: focus group study</article-title>. <source>BMJ</source>
<year>2002</year>; <volume>325</volume>: <fpage>581</fpage>&#x02013;<lpage>585</lpage>.<pub-id pub-id-type="pmid">12228136</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="ehf212027-cit-0066">
<string-name>
<surname>Alba</surname>
<given-names>AC</given-names>
</string-name>, 
<string-name>
<surname>Agoritsas</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Jankowski</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Courvoisier</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Walter</surname>
<given-names>SD</given-names>
</string-name>, 
<string-name>
<surname>Guyatt</surname>
<given-names>GH</given-names>
</string-name>, 
<string-name>
<surname>Ross</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review</article-title>. <source>Circ Heart Fail</source>
<year>2013</year>; <volume>6</volume>: <fpage>881</fpage>&#x02013;<lpage>889</lpage>.<pub-id pub-id-type="pmid">23888045</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="ehf212027-cit-0067">
<string-name>
<surname>Di Angelantonio</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Chowdhury</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Sarwar</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Ray</surname>
<given-names>KK</given-names>
</string-name>, 
<string-name>
<surname>Gobin</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Saleheen</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Thompson</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Gudnason</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Sattar</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Danesh</surname>
<given-names>J</given-names>
</string-name>. <article-title>B&#x02010;type natriuretic peptides and cardiovascular risk: systematic review and meta&#x02010;analysis of 40 prospective studies</article-title>. <source>Circulation</source>
<year>2009</year>; <volume>120</volume>: <fpage>2177</fpage>&#x02013;<lpage>2187</lpage>.<pub-id pub-id-type="pmid">19917883</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="ehf212027-cit-0068">
<string-name>
<surname>Hudson</surname>
<given-names>MP</given-names>
</string-name>, 
<string-name>
<surname>O'Connor</surname>
<given-names>CM</given-names>
</string-name>, 
<string-name>
<surname>Gattis</surname>
<given-names>WA</given-names>
</string-name>, 
<string-name>
<surname>Tasissa</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Hasselblad</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Holleman</surname>
<given-names>CM</given-names>
</string-name>, 
<string-name>
<surname>Gaulden</surname>
<given-names>LH</given-names>
</string-name>, 
<string-name>
<surname>Sedor</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Ohman</surname>
<given-names>EM</given-names>
</string-name>. <article-title>Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis</article-title>. <source>Am Heart J</source>
<year>2004</year>; <volume>147</volume>: <fpage>546</fpage>&#x02013;<lpage>552</lpage>.<pub-id pub-id-type="pmid">14999208</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="ehf212027-cit-0069">
<string-name>
<surname>de Antonio</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Lupon</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Galan</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Vila</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Urrutia</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Bayes&#x02010;Genis</surname>
<given-names>A</given-names>
</string-name>. <article-title>Combined use of high&#x02010;sensitivity cardiac troponin T and N&#x02010;terminal pro&#x02010;B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure</article-title>. <source>Am Heart J</source>
<year>2012</year>; <volume>163</volume>: <fpage>821</fpage>&#x02013;<lpage>828</lpage>.<pub-id pub-id-type="pmid">22607860</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="ehf212027-cit-0070">
<string-name>
<surname>Adler</surname>
<given-names>ED</given-names>
</string-name>, 
<string-name>
<surname>Goldfinger</surname>
<given-names>JZ</given-names>
</string-name>, 
<string-name>
<surname>Kalman</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Park</surname>
<given-names>ME</given-names>
</string-name>, 
<string-name>
<surname>Meier</surname>
<given-names>DE</given-names>
</string-name>. <article-title>Palliative care in the treatment of advanced heart failure</article-title>. <source>Circulation</source>
<year>2009</year>; <volume>120</volume>: <fpage>2597</fpage>&#x02013;<lpage>2606</lpage>.<pub-id pub-id-type="pmid">20026792</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="ehf212027-cit-0071">
<string-name>
<surname>Haga</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Murray</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Reid</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Ness</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>O'Donnell</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Yellowlees</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Denvir</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Identifying community based chronic heart failure patients in the last year of life: a comparison of the Gold Standards Framework Prognostic Indicator Guide and the Seattle Heart Failure Model</article-title>. <source>Heart</source>
<year>2012</year>; <volume>98</volume>: <fpage>579</fpage>&#x02013;<lpage>583</lpage>.<pub-id pub-id-type="pmid">22422744</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="ehf212027-cit-0072">
<string-name>
<surname>Hogg</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Jenkins</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Prognostication or identification of palliative needs in advanced heart failure: where should the focus lie?</article-title>
<source>Heart</source>
<year>2012</year>; <volume>98</volume>: <fpage>523</fpage>&#x02013;<lpage>524</lpage>.<pub-id pub-id-type="pmid">22422741</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="ehf212027-cit-0073">
<string-name>
<surname>Waller</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Girgis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Lecathelinais</surname>
<given-names>C</given-names>
</string-name>, <article-title>Palliative Care Research Program team. Development of the palliative care needs assessment tool (PC&#x02010;NAT) for use by multi&#x02010;disciplinary health professionals</article-title>. <source>Palliat Med</source>
<year>2008</year>; <volume>22</volume>: <fpage>956</fpage>&#x02013;<lpage>964</lpage>.<pub-id pub-id-type="pmid">18952754</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="ehf212027-cit-0074">
<string-name>
<surname>Waller</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Girgis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Lecathelinais</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Scott</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Foot</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Sibbritt</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>D</given-names>
</string-name>, <article-title>Palliative Care Research Program t. Validity, reliability and clinical feasibility of a Needs Assessment Tool for people with progressive cancer</article-title>. <source>Psychooncology</source>
<year>2010</year>; <volume>19</volume>: <fpage>726</fpage>&#x02013;<lpage>733</lpage>.<pub-id pub-id-type="pmid">19777532</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="ehf212027-cit-0075">
<string-name>
<surname>Waller</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Girgis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Johnson</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Lecathelinais</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Sibbritt</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Forstner</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Liauw</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Improving outcomes for people with progressive cancer: interrupted time series trial of a needs assessment intervention</article-title>. <source>J Pain Symptom Manage</source>
<year>2012</year>; <volume>43</volume>: <fpage>569</fpage>&#x02013;<lpage>581</lpage>.<pub-id pub-id-type="pmid">22209224</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="ehf212027-cit-0076">
<string-name>
<surname>Waller</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Girgis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Davidson</surname>
<given-names>PM</given-names>
</string-name>, 
<string-name>
<surname>Newton</surname>
<given-names>PJ</given-names>
</string-name>, 
<string-name>
<surname>Lecathelinais</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Macdonald</surname>
<given-names>PS</given-names>
</string-name>, 
<string-name>
<surname>Hayward</surname>
<given-names>CS</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Facilitating needs&#x02010;based support and palliative care for people with chronic heart failure: preliminary evidence for the acceptability, inter&#x02010;rater reliability, and validity of a needs assessment tool</article-title>. <source>J Pain Symptom Manage</source>
<year>2013</year>; <volume>45</volume>: <fpage>912</fpage>&#x02013;<lpage>925</lpage>.<pub-id pub-id-type="pmid">23017612</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="ehf212027-cit-0077">
<string-name>
<surname>Nikoletti</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Porock</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Kristjanson</surname>
<given-names>LJ</given-names>
</string-name>, 
<string-name>
<surname>Medigovich</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Pedler</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Smith</surname>
<given-names>M</given-names>
</string-name>. <article-title>Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale</article-title>. <source>J Palliat Med</source>
<year>2000</year>; <volume>3</volume>: <fpage>301</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">15859671</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="ehf212027-cit-0078">
<string-name>
<surname>Kaasa</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Wessel</surname>
<given-names>J</given-names>
</string-name>. <article-title>The Edmonton Functional Assessment Tool: further development and validation for use in palliative care</article-title>. <source>J Palliat Care</source>
<year>2001</year>; <volume>17</volume>: <fpage>5</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">11324186</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="ehf212027-cit-0079">
<string-name>
<surname>Abernethy</surname>
<given-names>AP</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>DC</given-names>
</string-name>, 
<string-name>
<surname>Hunt</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Williams</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Roder&#x02010;Allen</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Rowett</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Shelby&#x02010;James</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Esterman</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>May</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Phillips</surname>
<given-names>PA</given-names>
</string-name>. <article-title>A pragmatic 2 x 2 x 2 factorial cluster randomized controlled trial of educational outreach visiting and case conferencing in palliative care&#x02010;methodology of the Palliative Care Trial [ISRCTN 81117481]</article-title>. <source>Contemp Clin Trials</source>
<year>2006</year>; <volume>27</volume>: <fpage>83</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">16290094</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="ehf212027-cit-0080">
<string-name>
<surname>Karnofsky</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Abelmann</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Craver</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Burchenal</surname>
<given-names>J</given-names>
</string-name>. <article-title>The use of nitrogen mustard in hte palliative treatment of cancer</article-title>. <source>Cancer</source>
<year>1948</year>; <volume>1</volume>: <fpage>634</fpage>&#x02013;<lpage>656</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="ehf212027-cit-0081">
<string-name>
<surname>Abernethy</surname>
<given-names>AP</given-names>
</string-name>, 
<string-name>
<surname>Shelby&#x02010;James</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Fazekas</surname>
<given-names>BS</given-names>
</string-name>, 
<string-name>
<surname>Woods</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Currow</surname>
<given-names>DC</given-names>
</string-name>. <article-title>The Australia&#x02010;modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]</article-title>. <source>BMC Palliative Care</source>
<year>2005</year>; <volume>4</volume>: <fpage>7</fpage>.<pub-id pub-id-type="pmid">16283937</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="ehf212027-cit-0082">
<string-name>
<surname>Paulus</surname>
<given-names>WJ</given-names>
</string-name>, 
<string-name>
<surname>Tschope</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Sanderson</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Rusconi</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Flachskampf</surname>
<given-names>FA</given-names>
</string-name>, 
<string-name>
<surname>Rademakers</surname>
<given-names>FE</given-names>
</string-name>, 
<string-name>
<surname>Marino</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Smiseth</surname>
<given-names>OA</given-names>
</string-name>, 
<string-name>
<surname>De Keulenaer</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Leite&#x02010;Moreira</surname>
<given-names>AF</given-names>
</string-name>, 
<string-name>
<surname>Borbely</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Edes</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Handoko</surname>
<given-names>ML</given-names>
</string-name>, 
<string-name>
<surname>Heymans</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Pezzali</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Pieske</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Dickstein</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Fraser</surname>
<given-names>AG</given-names>
</string-name>, 
<string-name>
<surname>Brutsaert</surname>
<given-names>DL</given-names>
</string-name>. <article-title>How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology</article-title>. <source>Eur Heart J</source>
<year>2007</year>; <volume>28</volume>: <fpage>2539</fpage>&#x02013;<lpage>2550</lpage>.<pub-id pub-id-type="pmid">17428822</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="ehf212027-cit-0083">
<string-name>
<surname>Jackson</surname>
<given-names>CE</given-names>
</string-name>, 
<string-name>
<surname>Myles</surname>
<given-names>RC</given-names>
</string-name>, 
<string-name>
<surname>Tsorlalis</surname>
<given-names>IK</given-names>
</string-name>, 
<string-name>
<surname>Dalzell</surname>
<given-names>JR</given-names>
</string-name>, 
<string-name>
<surname>Spooner</surname>
<given-names>RJ</given-names>
</string-name>, 
<string-name>
<surname>Rodgers</surname>
<given-names>JR</given-names>
</string-name>, 
<string-name>
<surname>Bezlyak</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Greenlaw</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Ford</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Cobbe</surname>
<given-names>SM</given-names>
</string-name>, 
<string-name>
<surname>Petrie</surname>
<given-names>MC</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Profile of microvolt T&#x02010;wave alternans testing in 1003 patients hospitalized with heart failure</article-title>. <source>Eur J Heart Fail</source>
<year>2012</year>; <volume>14</volume>: <fpage>377</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">22334727</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="ehf212027-cit-0084">
<string-name>
<surname>Evangelista</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Flachskampf</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Lancellotti</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Badano</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Aguilar</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Monaghan</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Zamorano</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Nihoyannopoulos</surname>
<given-names>P</given-names>
</string-name>. <article-title>European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies</article-title>. <source>European Journal of Echocardiography: the Journal of the Working Group on Echocardiography of the European Society of Cardiology</source>
<year>2008</year>; <volume>9</volume>: <fpage>438</fpage>&#x02013;<lpage>448</lpage>.</mixed-citation></ref><ref id="ehf212027-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="ehf212027-cit-0085">
<string-name>
<surname>Lang</surname>
<given-names>RM</given-names>
</string-name>, 
<string-name>
<surname>Bierig</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Devereux</surname>
<given-names>RB</given-names>
</string-name>, 
<string-name>
<surname>Flachskampf</surname>
<given-names>FA</given-names>
</string-name>, 
<string-name>
<surname>Foster</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Pellikka</surname>
<given-names>PA</given-names>
</string-name>, 
<string-name>
<surname>Picard</surname>
<given-names>MH</given-names>
</string-name>, 
<string-name>
<surname>Roman</surname>
<given-names>MJ</given-names>
</string-name>, 
<string-name>
<surname>Seward</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Shanewise</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Solomon</surname>
<given-names>SD</given-names>
</string-name>, 
<string-name>
<surname>Spencer</surname>
<given-names>KT</given-names>
</string-name>, 
<string-name>
<surname>Sutton</surname>
<given-names>MS</given-names>
</string-name>, 
<string-name>
<surname>Stewart</surname>
<given-names>WJ</given-names>
</string-name>. <article-title>Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology</article-title>. <source>Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography</source>
<year>2005</year>; <volume>18</volume>: <fpage>1440</fpage>&#x02013;<lpage>1463</lpage>.<pub-id pub-id-type="pmid">16376782</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="ehf212027-cit-0086">
<collab collab-type="authors">World Medical Association</collab>
. <article-title>World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects</article-title>. <source>JAMA</source>
<year>2013</year>; <volume>310</volume>: <fpage>2191</fpage>&#x02013;<lpage>2194</lpage>.<pub-id pub-id-type="pmid">24141714</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="ehf212027-cit-0087">
<string-name>
<surname>Hudson</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Aranda</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>N</given-names>
</string-name>. <article-title>Randomized controlled trials in palliative care: overcoming the obstacles</article-title>. <source>Int J Palliat Nurs</source>
<year>2001</year>; <volume>7</volume>: <fpage>427</fpage>&#x02013;<lpage>434</lpage>.<pub-id pub-id-type="pmid">11832846</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="ehf212027-cit-0088">
<string-name>
<surname>Barnes</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Gott</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Payne</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Parker</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Seamark</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Gariballa</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Small</surname>
<given-names>N</given-names>
</string-name>. <article-title>Recruiting older people into a large, community&#x02010;based study of heart failure</article-title>. <source>Chronic Illn</source>
<year>2005</year>; <volume>1</volume>: <fpage>321</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">17152456</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="ehf212027-cit-0089">
<string-name>
<surname>Janssen</surname>
<given-names>DJ</given-names>
</string-name>, 
<string-name>
<surname>Wouters</surname>
<given-names>EF</given-names>
</string-name>, 
<string-name>
<surname>Schols</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Spruit</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Self&#x02010;perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol</article-title>. <source>BMC Palliative Care</source>
<year>2008</year>; <volume>7</volume>: <fpage>5</fpage>.<pub-id pub-id-type="pmid">18460203</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="ehf212027-cit-0090">
<string-name>
<surname>Campbell</surname>
<given-names>RT</given-names>
</string-name>, 
<string-name>
<surname>McMurray</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Comorbidities and differential diagnosis in heart failure with preserved ejection fraction</article-title>. <source>Heart Fail Clin</source>
<year>2014</year>; <volume>10</volume>: <fpage>481</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">24975911</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="ehf212027-cit-0091">
<string-name>
<surname>Gure</surname>
<given-names>TR</given-names>
</string-name>, 
<string-name>
<surname>Blaum</surname>
<given-names>CS</given-names>
</string-name>, 
<string-name>
<surname>Giordani</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Koelling</surname>
<given-names>TM</given-names>
</string-name>, 
<string-name>
<surname>Galecki</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Pressler</surname>
<given-names>SJ</given-names>
</string-name>, 
<string-name>
<surname>Hummel</surname>
<given-names>SL</given-names>
</string-name>, 
<string-name>
<surname>Langa</surname>
<given-names>KM</given-names>
</string-name>. <article-title>Prevalence of cognitive impairment in older adults with heart failure</article-title>. <source>J Am Geriatr Soc</source>
<year>2012</year>; <volume>60</volume>: <fpage>1724</fpage>&#x02013;<lpage>1729</lpage>.<pub-id pub-id-type="pmid">22882000</pub-id></mixed-citation></ref><ref id="ehf212027-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="ehf212027-cit-0092">
<string-name>
<surname>Formiga</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Olmedo</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Lopez&#x02010;Soto</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Navarro</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Culla</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Pujol</surname>
<given-names>R</given-names>
</string-name>. <article-title>Dying in hospital of terminal heart failure or severe dementia: the circumstances associated with death and the opinions of caregivers</article-title>. <source>Palliat Med</source>
<year>2007</year>; <volume>21</volume>: <fpage>35</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">17169958</pub-id></mixed-citation></ref></ref-list></back></article>